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Abstract 
 
In this thesis was described the mutagenesis, expression, purification and crystallization 
of three mutants of TupA as well as the evaluation of the solved structure of TupA. The three 
mutants were crystallized in PEG8000; however, the diffraction experiment showed the bad 
quality of the crystals. Optimization of the crystallization conditions of the mutated forms and 
native protein in the presence and absence of ligands are under way. ModA had previously 
been expressed, purified, crystallized and the crystal diffracted up to 3.5 Å resolution, ongoing 
the optimization trials. ModA crystallized in PEG6000 and also with Benzamidine-HCl, diffracting 
up to 2.77 Å resolution. Crystallization in the presence of metals is underway for TupA and 
ModA proteins. By SAXS technique, we determined low resolution models for ModA in solution 
and in the presence and absence of ligands. 
Biochemical characterization of the two proteins and corresponding mutants was 
developed through analysis of native gels, where TupA describes a higher conformational 
change when is binding to tungstate; however it can also binding molybdate. The 
conformational change of ModA is similar whether connected to the molybdate or tungstate. 
The mutation of R to K kills the binding with the molybdate but not with tungstate, while the 
other two mutants seem to have no binding for molybdate and decrease for tungstate. In order 
to defining the KD for TupA, competitive studies were performed by ITC. The same strategy 
wasn’t possible for ModA, since its high and equivalent affinity for both ligands. The results 
obtained for mutants by ITC also confirm those obtained for the native gels. The analysis of 
urea gels suggests a conformational change since TupA adopts a more compact conformation 
when bound tungstate but not to the molybdate. In ModA, the same behavior is observed, 
proposing that this protein is less selective than TupA. Concerning mutated forms of TupA, no 
conformational change was found.  
Keywords: Molybdenum, Tungsten, X-ray crystallography, Isothermal titration calorimetry, ABC 
transporters, Small angle X-rays scattering 
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Resumo  
 
Nesta dissertação foram descritas técnicas como mutagénese, expressão,  purificação 
e cristalização de três mutantes da TupA bem como a avaliação da estrutura da proteína 
nativa. Os três mutantes cristalizaram em PEG8000, contudo a experiência de difracção 
demonstrou a má qualidade dos cristias. A optimização das condições de cristalização dos 
mutantes e da proteína nativa na presença e ausência de ligandos está a decorrer. A ModA foi 
previamente expressa, purificada, cristalizada, com uma difraação até 3.5 Å de resolução, 
optimizando-se as condições de cristalização. A ModA cristalizou em PEG6000 na presença de 
Benzamidina-HCl e difratou até 2.77 Å de resolução. A cristalização com metais está em curso 
para a TupA e ModA. Através da técnica de SAXS, determinaram-se modelos de baixa 
resolução para a ModA em solução, também na presença e ausência dos ligandos. 
A caracterização bioquímica das duas proteínas e dos mutantes correspondentes foi 
desenvolvida através da análise de  géis nativos, onde a TupA descreve uma elevada alteração 
conformacional quando ligada ao tungstato; contudo, consegue também ligar molibdato. A 
alteração conformacional da ModA é similar quando ligada ao molibdato ou tungstato. A 
mutação de R para K impede a ligação ao molibdato mas não ao tungstato, enquanto os outros 
dois mutantes parecem não ter qualquer ligação para o molibdato e apresentam um 
decréscimo para o tungstato. Para definir o KD da TupA efectuaram-se estudos de competição 
por ITC. A mesma estratégia não foi possível para a ModA, uma vez que esta aprenta elevada 
e equivalente afinidade aos ligandos. Os resultados obtidos para os mutants por ITC confirmam 
também os obtidos para os géis nativos. A análise dos géis de urea sugerem uma alteração 
conformacional dado que a TupA adopta uma conformação mais compacta quando ligada ao 
tungstato mas não ao molibdato. Na ModA, o mesmo não foi observado, propondo-se que esta 
proteína é menos selectiva que a TupA. Considerando os mutantes da TupA, não foram 
encontradas alterações conformacionais.  
Palavras-chave: Molibdénio, Tugsténio, Cristalografia de raios-X, Isothermal titration 
calorimetry, Transportadores ABC, Small angle x-ray scattering  
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1.1.  Molibdoenzymes and Tungstoenzymes 
  
1.1.1. The role of molybdenum and tungsten in nature 
 
Molybdenum (Mo) and tungsten (W) are chemically analogous elements that are found 
in the environment and the only second and third row transition metals that have a known 
biological function. They are found as extremely soluble oxoanions with almost identical co-
ordination chemistry.1, 2 Both elements Mo and W are associated with several redox active 
enzymes under physiological conditions. The physiological roles of these elements are 
fundamental and include the catalysis of some main reactions in the metabolism of carbon, 
nitrogen and sulfur by microorganisms, plants and animals, besides a small number of species 
that do not require molybdenum use tungsten for the same purpose.2-4  
Although tungsten not a universal bioelement, is broadly distributed in biology and is 
vital for some species. Nevertheless, in some cases tungsten seems be used because 
enviornmental restrictions. For the remaining species, tungsten is biochemical indifferent 
because they haven’t developed a functional use of the element, nevertheless, upon its 
inadvertent intake, their physiology might be affected.5  
Intake of Mo and W is achieved in the form of the corresponding oxoanions. This 
process should be regulated by the uptake system to select molybdate in the presence of 
competing anions, preventing toxycity symptoms or unavailability of Mo (lethal for the 
organism).5-7 
 
1.1.2.  The molybdenum cofactor 
 
Once uptake into the cell, molybdate requires to be coordinated by a unique scaffold to 
become biologically active. This molecule is a pyranopterin named molybdopterin (MPT) 
coordinated with Mo, formed the Mo cofactor (Moco). Moco biosynthesis can be distributed into 
four steps: conversion of GTP in cyclic pyranopterin monophosphate (cPMP, previously 
indentified as percursor Z); transformation of cPMP into MPT; metal incoporation; and finally in 
some organisms maturation to an active cofactor (figure 1.1). 7, 8  In eukaryots the pyranopterin 
is found in the simplest monophosphate form MPT, as already mention. However, in 
prokaryotes it is conjugated to nucleosides, usually cytosine (MCD, molybdopterin cytosine 
dinucleotide) or guanosine (MGD, molybdopterin guanosine dinucleotide), so there is an 
adicional step that binds Moco to different nucleotides (figure 1.2).9 The conversion of GTP to 
cPMP is catalyzed by two proteins; one of them (Cnx2 in plant, MOCS1A in humans and MoaA 
in E.coli) is a member of the superfamily of S- adenosylmethione (SAM)-dependent radical 
enzyme. Members of this protein family catalyze the formation of protein and/or substrate 
radicals by reductive cleavage of SAM involving the [4Fe-4S] cluster to generate the 5’-
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deoxyadenosyl radical which subsquently initiates the transformation of 5’-GTP bound to the C-
terminal [4Fe-4S] cluster. 10 
 
 Formerly, the sulfur is transferred to percursor Z in order to generate MPT. This 
reaction is catalyzed by the enzyme MPTsynthase consisting of two small (plant Cnx7, human 
MOCS2B) and two large (plant Cnx6, human MOCS2A) subunits capable of cPMP conversion 
to MPT (the sulfur is bound as thiocarboxylate to the C-terminal of the small subunit); after 
transfering the two sulfurs to percursor Z, the protein has to be re-sulfurated by the MPT 
synhtase sulfurase in order to reactivate the enzyme for the next reaction cycle of percursor Z 
conversion. This resulfuration is catalyzed by  MPT synthase sulfurase (Cnx5 in plants and 
MOCS3 in humans) and at this stage the sulfur transfer reaction in higher organisms seems to 
involve different protein components as the eukaryotic genes can not complement their bacterial 
counterparts.7, 11, 12 
 
 
  
Figure 1.1 - Biosynthesis of eukaryotic molybdenum cofactor. The names for the proteins from 
plants (green), humans (red) and E. coli (black) catalyzing the respective  steps are given.7 
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The insertion of Mo in MPT is not a spontaneous process; is catalyzed by a Mo-
insertase. In bacteria, Mo insertion is carried out by two distinctly expressed proteins (MogA and 
MoeA) although higher organisms have fused these two proteins to a single two domain protein 
(Geph in humans and Cnx1 in plants). Moco-synthetic proteins bind MPT with high affinity and 
participate in the Mo insertion reaction. 7, 11 
In bacteria, additional modifications by covalent addition of GTP or CTP to MPT are 
necessary to produce both MGD and MCD. So, MGD is formed by the MobA protein which 
specifically binds GTP, while MCD is formed by MocA protein which acts specifically on CTP. In 
both cases, it has been shown that addition of the dinucleotide to the cofactor occurs after the 
insertion of Mo into MTP. 9, 13 
 
 
 
 
 
 
 
 
 
 
 
1.1.2.1. Importance of molybdenum containing enzymes  
 
The Mo enzymes SO (sulfite oxidase) and DMSO (dimethylsulfoxide reductase) are 
important to the global sulfur cycle. The reduction of DMSO produces dimethyl sulfide which is 
photo-oxidized to methanesulfonic acid. This compound is eventually metabolized to sulfite by 
soil bacteria and then oxidized to sulfate by the sulfite oxidase. 14 
So, a deficiency of Mo enzymes or Moco can be dramatic, especially in humans. Moco 
insufficiency is a hereditary recessive disorder that affects neonates soon after birth. The major 
cause of the disease resides in the loss of sulfide oxidase, which effectively removes sulfite 
from human body. A damage in sulfide oxidase activity results in the accumulation of sulfite, 
ultimately causing severe neurological damage, disordered autonomic function, dysmorphic 
facial features, progressive cerebral palsy, seizures and death.15, 16 
  
Figure 1.2 – Molybdopterin dinucleotide biosynthesis13 
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As it was already mentioned Moco catalyzes important redox reactions in the global 
carbon, sulfur and nitrogen cycles. So, on the basis of cofactor composition and catalytic 
function there are two different groups11: 
I. Mo-dependent nitrogenase that contains an Fe-Moco in the active site; 
II. All other molydoenzymes that bind Moco 
 
Nitrogenase is essential for biological nitrogen fixation which is an essential step in the 
nitrogen cycle in the biosphere. It reduces atmospheric pressure with high-energy input in the 
form of ATP. However, four different types of nitrogenases have been identified, each of which 
has a particular combination of metals in the active site. The most abundant is the Fe-Mo-
dependent nitrogenase which contains MoFe3S3 and Fe4S3.
8 
The second group of proteins which use Moco as cofactor involve SO, xanthine oxidase 
(XO) and DMSO families and the novel Moco-binding proteins. Each family includes a variety of 
subfamilies based on sequence similarity and substrate preferences (figure 1.3).8 
In E. coli, the XO family contains the MCD. The SO family is characterized by a di-
oxoMoco with an additional protein ligand, which usually is a cysteine. The DMSO family 
contains two MGDs connect to one Mo atom with additional ligands being an O/S, and a sixth 
ligand X which can be a serine, a cysteine, a selenocysteine, an aspartate or a hydroxide and/or 
water molecule.13 
 
       
 
 
 
 
 
 
 
  
Figure 1.3 – Different structures of the molybdenum cofactor in E. coli. The basic form of the Moco is 
MPT with a unique dithiolene group coordinating the Mo atom. Moco exists in different variants and is 
divided into three molybdenum-containing enzyme families agreeing to the coordination at the Mo 
atom as it was said before.14 
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1.1.3.  The tungsten cofactor 
 
In contrast of Moco synthesis, the Wco synthesis has not been studied so far. However, 
it is expected that the basic mechanisms of Wco and Moco synthesis are similar since almost all 
genes that have an assigned function in the Moco biosynthetic pathway are also present in the 
genome of organisms that use tungsten in their metabolism. Main differences should occur in 
the metal insertion step as here a specific discrimination between Mo and W is crucial, as we 
will see later. 17, 18 
Tungsten is sequestered and transported into the cytoplasm as tungstate. It may then 
enter the biosynthetic machinery to be bound to dithiolene-functionality of a tricyclic pterin 
moiety to form tungstopterin (W-MPT) and finally end up in tungstoenzymes in the form of a 
complex metal-organic cofactor: tungsto-bispterin (W-bis-MPT) or tungsto-bispterin guanine 
dinucleotide (W-bis-MGD) (figure 1.4). 5 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.4 – Wco biosynthesis in E.coli. The conversion of GTP in MTP occurs like the Moco biosynthesis. 
Then, MPT is adenylylated by the action of the hexameric MoaB (in P.furiosus), a function which is identical 
to the trimeric MogA protein found in E. coli. Next, the metal is inserted by MoeA1 or MoeA2 or both. Finally, 
guanylylation has to be catalyzed by the MobA protein (adaptation).17, 18, 19 
W-bis-MPT 
W-bis-MGD 
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As it was said, there are main differences in the metal insertion step, for example, the 
tungstate transporter from P. furiosus selectively binds tungstate with a 1000-folder higher 
affinity over molybdate. MogA and MoeA are known to be important for E.coli Mo insertion, 
however, in P.furiosus and other archea only the MogA-homologous, MoaB proteins, are found. 
In addition, two different MoeA orthologs are present in these genomes. 17 
P.furiosus is strictly dependent on tungstate, so it is a model organism to study Wco 
biosynthesis. 17 In E.coli the biosynthesis of Wco begins as Moco, with the conversion called 
precursor Z or cPMP, catalyzed by two proteins MoaA and MoaC. Consequently, the MPT is 
synthesized from cPMP by MTP synthase which involves MoaD and MoaE proteins. The next 
step includes the insertion of the metal atom to the dithiolene sulfurs of one or two MPT 
moieties.5, 19  Though, with the tungsten there are always two pterin moieties. The protein MogA 
plays a role in this step, and recently MoaB was found to be involved in this stage of the 
cofactor synthesis; these proteins catalyze the activation of MPT by adenylation with Mg-ATP. 
The trimeric MogA proteins are commonly found in bacteria and eukaryotes whereas the 
hexameric MoaB proteins are mostly found in archea.17, 20 
 MoeA is believed to bind the adenylylated MPT (MPT-AMP) and, in the presence of 
tungstate, the MPT-AMP complex is hydrolyzed, tungsten is incorporated through binding to the 
dithiolene sulfur resulting in tungstobispterin (W-bis-MPT) and AMP is released. This suggested 
role for MoeA in E.coli is based on the activity of its plant homologue: Cnx1E, which catalyzes 
the hydrolysis of MPT-AMP in the presence of molybdate.12  When molybdate was replaced with 
tungstate the hydrolysis catalyzed by Cnx1E was considerably less efficient and this effect 
suggests that Cnx1E and homologues possibly will play a role in selectively incorporating either 
tungsten or molybdenum in MPT.5, 12 Several bacterial genomes and all archea genomes 
sequenced until now, contain two different moeA genes which share nearly 40% sequence 
identity.12 The presence of these two MoeA’s can then explain how organisms are able to 
regulate and express two enzymes, one with Moco and the other with Wco in the active 
center.17 
 Another possible pathway is with the MobA protein, resulting in a tungsten center 
coordinated by four dithiolene sulfur ligands, the tungstobispterin guanine dinucleotide form (W-
bis-MGD).21  
 
1.1.3.1. Importance of tungsten containing enzymes 
 
The AORs (Aldehyde oxirreductases) family can catalyze aldehyde oxidation to 
carboxylic acids and in some cases carboxylic acid reduction to aldehydes. The latter reaction is 
of particular interest for potential biotechnological applications of these enzymes, since 
aldehydes are highly valued compounds for the fine-chemical industry.18   
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Prokaryotic FDHs (Formate dehydrogenases), with W in the active site, have the 
capability to catalyze the reverse reaction, i.e. the reduction of CO2 to formate. Consequently, 
tungsten-containing FDHs have a great potential as catalysts capable to fix CO2 from the 
atmosphere to produce reduced carbon compounds that could be used as fuels. FDHs have the 
advantage over chemical catalysts as they work as homogeneous catalysts generating formate 
as sole product which is being known as an alternative energy source through fuel cells based 
on formic acid. Understanding the molecular features that control the substrate specificity and 
direction of the reaction (oxidation or reduction) in FDHs, would permit to design biocatalysts 
and improve procedures related to bioremediation and generation of alternative energy 
sources.18, 22, 23 
In the following years, tungsten-containing enzymes were purified from bacteria and 
homologous genes are even found in the genomes of some organisms, proposing that tungsten 
enzymes are present in a much wider range of microorganisms. There have been no reports so 
far on any tungsten enzymes in eukaryotes.5, 24  The tungsten-containing enzymes can be 
divided into two families:  
I. Aldehyde oxirreductases (AORs) that contain a non-modified tungsto-bispterin cofactor;  
II. Formate dehydrogenases (FDHs) which have a guanine monophosphate attached to 
each pterin moiety.5 
 
The enzymes in the AOR family catalyze the oxidation of aldehydes to carboxylic acids, 
and they use ferredoxin as redox partner protein. They are generally oxygen sensitive and 
typically have broad substrate specificities with partial correspondence between enzymes from 
the same species.5, 14 The enzymes of FDHs family catalyze the oxidation of formate to carbon 
dioxide. The enzymes exhibit a great variety of redox partners and in most cases the 
physiological redox partner has not been identified.5, 14 
 
1.1.4. The uptake of molybdate and tungstate by ModA and TupA 
 
ATP-binding cassette (ABC) transporter proteins bring different substrates through cell 
membranes. Bacterial ABC importers are clinically important ABC transporters implicated in 
various diseases or origin multidrug resistance of cancer cells. In contrast these transport 
systems are essential for the uptake of nutrients, including rare elements like molybdenum and 
tungsten .25 
In prokaryotes, Mo and W are transported as soluble molybdate and tungstate 
oxoanions, respectively, by the high affinity Mod/Tup/WtpABC transport systems. The 
mod/tupABC genes encode the proteins Mod/TupA, Mod/TupB and Mod/TupC, which together 
assemble into the Mod/TupABC transporter. The motif (cassette) of amino acids establishing 
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the ATP binding site on the protein Mod/TupC is positioned on the cytoplasmic site of native 
Mod/TupABC complex; Mod/TupB is in the transmembrane protein and finally, Mod/TupA is the 
molybdate-binding protein on the periplasmic site.26, 27 
 
The WtpA protein integrates an ABC transporter specific for the tungstate uptake in 
presence of molybdate. The gene wtpabc which encodes the three different components as 
mentioned for TupABC and ModABC is present in several archea and some bacteria; the 
previous characterization of this transporter clarified the transport mechanism of these anions in 
organisms that lack the known uptake systems related with the ModA and also TupA proteins. 
Basically, the three transporters families differ to each other in protein sequence but also in 
activity for their periplasmic binding proteins and in the coordination chemistry of the anions.28-30  
 
In this master thesis only the subunit A of the transport system ModABC and TupABC 
were studied and analyzed.  
The periplasmic protein ModA binds specifically molybdate and also tungstate but it is 
not specific for other anions. The reason behind this is because the specificity for these anions 
and ModA are typically determined by the size of the binding pocket.28 ModA proteins cannot 
differentiate between molybdate and tungstate in presence of both. On the other hand, the 
periplasmic tungsten protein TupA showed that binds tungstate with high affinity, however it can 
bind also molybdate but not with the same specificity. This periplasmic protein is able to 
discriminate between both anions.28, 30 Molybdate or tungstate binds to the component A of the 
transporter, making this protein the first selection gate from which cells can should differentiate 
among Mo or W.18  
The component B of the transport system is composed by two transmembrane domains 
(TMDs) that form the translocation pathway which are associated with the component C that 
include two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP.31, 32 The 
importers' resting state is inward-facing, where the NBD dimer interface is held open by the 
TMDs and facing outward. When the closed, substrate-loaded binding protein attaches near the 
periplasmic side of the transmembrane domains, the ATP binds and the NBD dimer closes. The 
resting state of the transporter changes into an outward-facing conformation in which the TMDs 
have reoriented themselves. So then, they are capable to accept the substrate from the binding 
protein. After the ATP has been hydrolyzed, the NBD dimer opens up and the substrate is 
released into the cytoplasm. The transporter then reverts back to its resting state upon the 
release of phosphate and ADP.33, 34   Essentially, molybdenum as well tungsten goes into the 
cell as via ATP binding cassette and it is subsequently incorporated by complex biosynthetic 
machineries into metal cofactors.16  
However, other proteins encoded by different operons have functions in intracellular 
molybdate and tungstate binding and regulation of gene expression. These modABC operon or 
gene cluster tupABC are organized encoding additional proteins such as ModE, a repressor 
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DNA-binding protein in the case of ModABC operon.27, 30, 35 The ModE transcription factor is 
encoded by the modEF operon immediately upstream of modABC.18 E.coli ModE controls gene 
expression of the mod by distinguishing molybdate concentrations.  The expression of operons 
in molybdate uptake or molybdopterin (MPT) synthesis is regulated depending on the 
molybdate status. In the presence of high concentrations of molybdate the mod operon is 
repressed while the moa operon is induced in order to produce sufficient MPT scaffolds to bind 
molybdate, meaning that when ModE binds Mo undergoes conformational rearrangement and 
dimerization.18, 36-39  
 
1.2. Sulfate reducing bacteria: Desulfovibrio alaskensis G20 
 
The sulfate reducing bacteria (SBR) are anaerobic microorganisms that are general in 
anoxic environments where they use sulfate as a terminal electron acceptor for the degradation 
of organic compounds, causing the production of sulfide which is incorporated in amino acids 
and enzymes with sulfur.40 These anoxic bacteria have high metabolic versatility, because they 
can use a wide range of other substrates and also play an important role in the cycle of different 
elements like sulfur and carbon.41  
These kinds of microorganisms are also important in the bioremediation of heavy metals 
and in the elimination of sulfur compounds from the combustion waste water and gas. On the 
other hand, they are still involved in bio corrosion of ferrous metals in anaerobic environments, 
initiating several problems for some industries due to excessive production of sulfides, which 
are extremely toxic and corrosive.40, 41 
In SBR, a tight regulation of intracellular concentrations of Mo and W is especially 
important because these metals suppress the SBR growth. The inhibition of SBR growth is 
frequently used for prevention and control of the microbial bio corrosion process. 42 
The analysis of the D. alaskensis G20 genome exposes two moeA-like genes sharing 
32.5% sequence identity (Dde_0230 and Dde_3228, respectively), proposing that this 
hypothesis may also be suggested for this organism. D.alaskensis G20 contains a Mo transport 
system encoded by the mod gene cluster and similarly, the proteins putatively involved in 
tungstate transport are encoded by the tup genes.43 
One of the goals of this thesis is to structurally characterize the two transporters TupA 
and ModA and determine the interaction with the respective oxoanions. For this reason, a short 
introduction to the techniques used is going to be provided. 
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1.3. X-rays Crystallography 
 
Several techniques are currently used to determine the structure of a protein, including 
X-ray crystallography, NMR spectroscopy and electron microscopy.44  
X-ray crystallography is presently the main technique for the determination of protein 
structures. Knowledge of the three-dimensional structure of proteins can be used in various 
applications, namely, in biotechnology, biomedicine and drug design as well as a validation tool 
for protein modifications, ligand binding and also structural authenticity.45 The extension of the 
technique to systems such as viruses, immune complexes and protein-nucleic acid complexes 
serves only to widen the appeal of crystallography.46 Besides, the requirement for pure, 
homogeneous and stable protein solutions in crystallizations makes X-ray crystallography useful 
in other fields of protein research as well.45  
In this master thesis we will be discuss the different steps from the crystallization 
conditions until crystals and finally the validation of the structure.  
 
1.3.1. X-rays 
 
In 1895, a german physicist, Wilhelm Rontgen discovered the X-rays being awarded the 
very first Nobel Prize in Physics in 1901. 47  X-rays have the proper wavelength (in the Angstrom 
range ~10-10m) to be scattered by the electron cloud of an atom of comparable size. The X-rays 
radiation, in electromagnetic spectrum, is between UV and Ɣ-rays (figure 1.5).48 
 
 
 
 
 
 
 
 
Figure 1.5- The electromagnetic spectrum. X-ray band highlighted in yellow over toward the right. The X-
rays have shorter wavelengths, higher frequencies and higher energy than most other types of 
electromagnetic radiation and don’t penetrate Earth’s atmosphere. Their wavelengths are around the same 
scale as atomic sizes (adaptation)49  
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Fundamental electromagnetic theory states that when a charged particle is accelerated 
through a magnetic field, electromagnetic radiation is emitted. The introduction of synchrotron 
radiation facilities constitutes a revolution in X-ray macromolecular crystallography since a 
monochromatic and highly intense X-ray beam can be produced and used for diffraction 
experiments. 50 The X-rays can be generated from accelerating electrons in a synchrotron 
storage ring. A single X-ray wavelength is usually selected by absorption of unwelcome 
wavelengths in a procedure known as monochromation. The X-rays must be focused into a 
beam and then collimated to certify that the beam is parallel (figure 1.6).46  
 
 
 
 
 
 
 
 
 
 
Figure 1.6- How is synchrotron light created. 1 – Electron gun, 2 – Linac, 3 - Booster ring, 4 – Storage 
ring, 5 – Beamline, 6 – End station. Electrons are generated in the center (1) and accelerated of 99.9997% 
of the speed of light by the linear accelerator (2). The electrons are transferred to the booster ring (3), 
where they are increased in energy. They are then transferred to the outer storage ring (4) (adaptation). 51 
 
1.3.2.  Protein Crystallization 
 
The determination of the structure of biological macromolecules by X-ray 
crystallography relies on previous steps as selection of the target molecule, cloning, expression, 
purification and crystallization; collection of diffraction data until the determination of atomic 
positions. Though, even when pure soluble protein is available, producing high-quality crystals 
remains a major block in structure determination. So, it is important to find appropriate 
crystallization conditions and optimize growth of diffraction-quality crystal as well.52 
The main aspect of a crystal is its internal structure, three-dimensionally ordered and 
periodic, where the molecules are packed and interacting through non covalent interactions.53 A 
crystal is characterized by a periodically  arranged unit called unit cell that is distributed in the 
three dimensions as a lattice48, 54 
The unit cell is defined by the unit cell parameters a,b and c, with respective angles α 
(between b and c), β (between a and c) and Ɣ (between a and b) (figure 1.7).55  
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The unit cells parameters may diverge causing seven crystal systems, which represent 
different organizations inside the crystal (Appendix I). The crystal symmetry operations found in 
chiral molecules, only include translation and rotation, limitating the number of possible space 
groups of biomolecules form 230 to 65.56  
  
 
 
 
 
 
 
Figure 1.7 – Schematic representation of crystal by various unit cells. There are six unit cells in a 
crystalline lattice where each cell contains two molecules. The positions of an atom is in the unit cell can 
be specified by a set of spatial coordinates x, y, z. (adaptation)56 
 
Usually protein crystals have very large solvent channels that occupy between 40-60% 
of the total volume. These solvent channels can be very useful for the study of protein-ligand 
interactions since they allow the access of the compound of interest in various areas of the 
protein and especially the active site.53, 57 
Crystallization is a complex process involving three stages: nucleation, crystal growth 
and cessation of growth. During nucleation, molecules associate in three dimensions to form a 
thermodynamically stable aggregate called nucleus. These nucleuses provide surfaces 
appropriate for crystal growth, which can occur between nucleation and metastable zone. At the 
stage of nucleation higher protein concentrations are needed when comparing with metastable 
zone in order to occur a slow precipitation promoting the formation of protein aggregates. This 
leads to a reduction of protein concentration in solution and the entry into the metastable zone.   
Crystal growth ends when the solution is sufficiently depleted of protein molecules, deformation-
induced strain destabilizes the lattice.52, 56, 58 
 Both crystal nucleation and growth occur in supersaturated solutions where the 
concentration of the protein exceeds its equilibrium solubility value. The area of metastable 
zone suitable for crystallization is generally represented on the phase diagram by the solubility 
curve (figure 1.8). The supersaturation requirements for nucleation and crystal growth are 
different. This is shown on the phase diagram where the supersaturation region is further 
divided into regions of higher supersaturation (the labile region), where both growth and 
nucleation occur, and lower supersaturation (the metastable region), where only growth is 
supported.58  
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Figure 1.8 – Schematic illustration of a protein crystallization phase diagram. The adjustable parameter 
can be the precipitant or additive concentration, pH or temperature. The solubility is defined as the 
concentration of protein in the solute that is in equilibrium with crystals. The supersolubilty curve is defined 
as the line separating conditions where spontaneous nucleation occurs from conditions where the 
crystallizations solution remains clear if it is left intact.59   
 
Despite the existence of many techniques to obtain crystals the most popular and used 
in this thesis is vapor diffusion. 
In vapor diffusion, crystals are prepared either using the hanging or sitting drop 
systems. Both consist in a drop containing a mixture of precipitant and protein solutions that are 
sealed in a chamber with concentrated precipitant. Water vapor diffuses out of the drop until the 
osmolarity of the drop and the precipitant are equal. The dehydration of the drop causes a slow 
concentration of both protein and precipitant until equilibrium is completed, ideally in crystal 
nucleation zone of the phase diagram.60  Basically in the hanging drop method the 
crystallization drop is hanging on top of the precipitant while in the sitting drop method it is 
laying on top of a small bridge (figure 1.9).  
Usually, protein crystallization is a challenging process dependent on the type of protein 
in study. Determination of the crystallization conditions usually requires testing different 
screenings, namely, precipitant solutions by varying the nature and concentration of salts, pH, 
additives and temperature. Among all precipitants, PEG (polyethylene glycols) with a low 
molecular weight (400-20000) is the most used.53  
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Figure 1.9 – Crystallization techniques by diffusion vapor. A – Schematic representation of hanging and 
sitting drop. B – Schematic representation of diffusion vapor method. The procedure begins in unsaturation 
zone and then progresses to nucleation zone because of water evaporation in the drop which incites an 
increase of protein concentration. (adaptation)58, 61 
 
1.3.3.  Diffraction, data-collection, phase problem and protein structure 
 
After the crystals growth, the next step is the diffraction experiment; however, it is 
necessary to harvest the crystals in the presence of cryo-protective agents (glycerol or 
paratone) before the diffraction. 
 In a diffraction experiment the crystal is subjected to an X-ray beam. Through this 
radiation interaction  with the electrons of the atoms that constitute the crystal, it originates a 
diffraction pattern with reflections which provide the internal organization of the crystalline lattice 
(figure 1.10).53, 62 
 
 
 
 
 
 
Figure 1.10 – Representation of X-rays diffraction. X-ray beams are shot through a crystal of the atom. 
The crystal causes the beam of X-ray to diffract in a predictable pattern based on their crystal lattice 
structure. The result is a diffraction pattern generally seen as the picture on the right. (adaptation)63-65  
The use of low temperatures during the experiment aims at reducing the diffraction 
radiation damage, enabling the collection of a complete data set from a single crystal using 
powerful sources. The cryo-protective agents minimize the scattering of X-rays by water 
molecules, since they prevent the formation of ice crystals on the surface and inside of the 
crystal protein.48, 62   
A 
B 
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The diffraction experiment can be explain by Bragg’s Law, which predicts that the 
strongest reflections off the crystal will occur for wavelengths such that the path difference 
between rays reflecting from consecutive layers in the lattice is equal to an integral number of 
wavelengths.66 For some particular crystal orientations, constructive interference between the 
rays going out of the crystal will be observed and will give the reflections that constitute a 
diffraction pattern in which the contribution of all atoms is present (figure 1.11).53, 56  
   
 
 
 
 
 
Figure 1.11 – Representation of Bragg’s Law. A diagram of a light beam impinging on a crystal lattice. If 
the light meets the criterion nλ = 2d sinϴ, Bragg’s law predicts that the waves reflecting off each layer of 
lattice interfere constructively, leading to a strong signal.66 
 As each reflection is constituted by a beam of X-rays, it can be defined as a periodic 
function, characterized by: amplitude, phase and wavelength. This characteristic allows the 
reflections to be defined with a Fourier transform using the structure factors, Fhkl.  
In order to reconstruct the electron density of the molecule, two parameters need to be 
provided for each reflection: the Fhkl which is directly obtained through the experiment and is 
proportional to the square root of the measured intensities making possible to determine the 
amplitudes |Fhkl|; and the phase angle of each reflection αhkl which is not directly observable 
making impossible to achieve the electron density map. This problem is commonly known as 
the famous Phase Problem in crystallography.53, 56, 57 
 Different methodologies are used to solve the phase problem, such as molecular 
replacement (MR), multiple isomorphous replacement (MIR) and multiple/ single wavelength 
anomalous dispersion (MAD/SAD). 
 The MR method is the most rapid and most recurrently used when a very closely related 
protein structure is accessible. The method comprises the crystallographic calculation in 
reverse: structure factors from the known coordinate file, it subsequent borrowing of the phases 
from the known model structure and their application to the new data set are used to calculate 
the new structure factor. This method has been used to solve the structure of TupA and will be 
used for the determination of the structure of ModA in the near future. 46, 67, 68  
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When MR method cannot be used to solve the phase problem, other methods as 
multiple isomorphous replacement (which requires a derivative dataset from protein crystal with 
attached heavy atoms) or multiple/ single wavelength anomalous dispersion (where anomalous 
scattering of X-rays according to the wavelength is used), have been developed. 
 The determination of the initial phases allows the determination of the first map of 
electron density which can provide the position of all atoms in the crystal.  
 
1.3.4.  Refinement and validation 
 
The quality of the electron density map may be upgraded by refinement.  The 
geometrical operation that connects the subunits can be used to control the electron density of 
the subunits in a series of cycles in which the phases are continually improved by a set of 
mathematical parameters and manual corrections. The phases are checked by paralleling the 
observed structure factors with the calculated ones, and the difference is expressed as a 
percentage known as the R factor (equation 1.1).46, 69 
  
 
 
In this expression, each |Fobs| is a consequence from measured reflection intensity and 
the |Fcalc| is the amplitude of the matching structure factor calculated from the current model.56  
 The R-factor combines the error inherent in the experimental data and the deviation of 
the model from reality. With increasingly better diffraction data, frequently characterized by 
Rmerge of 4% or less, the crystallographic R-factor is efficiently a measure of model errors. Well-
refined macromolecular structures are predictable to have R < 20%. When R approaches 30% 
should be considered with a high degree of reservation because at least, some parts of the 
model may be incorrect.53, 69   
 Another parameter that is considered is the Rfree. This is calculated analogously to 
normal R-factor, but for only ~ 1000 randomly selected reflections which have never entered 
into model refinement, although they might have influenced model definition. Rfree is an 
important validation parameter and should set a warning if it exceeds R by more than ~ 7%. Its 
high value may indicate over-fitting of the experimental data, or may result from a serious model 
defect.69 
Refinement and validation is done based on the previous knowledge of protein models 
and several parameters such as the root-mean-square (RMSD) deviations of all the model’s 
bond lengths and angles and Ramachandran diagram are considered. 
  
1.1 
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A B 
At the end, a good model of a protein structure is obtained which can be a valuable tool 
for functional and other structural studies. 
  
1.4. Small angle X-ray scattering 
 
With recent advances in data analysis algorithms, X-ray detectors and synchrotron 
sources, small-angle X-ray scattering (SAXS) has become more accessible to the structural 
biology community.70 This technique allows the analysis of the flexibility of the biological 
macromolecules in solution (nearly physiological conditions), which made this a major tool for 
the low-resolution structural characterization of biological macromolecules in solution. The most 
important limitation of current methods for reconstructing 3D models from SAXS is imposed by 
the requirement of solute monodispersity.71, 72 
Though limited to ∼10 Å resolution, SAXS can provide prosperity of structural 
information on biomolecules in solution and is compatible with a wide range of experimental 
conditions. SAXS is consequently an attractive alternative when crystallography is not possible. 
Furthermore, advanced use of SAXS can provide unique insight into bio molecular comportment 
that can only be detected in solution, such as large conformational changes and transient 
protein-protein interactions. Unlike crystal diffraction data, solution scattering data are subtle in 
appearance, highly sensitive to sample quality and experimental errors are easily 
misinterpreted.70  
Experimentally, this technique consists of exposing the protein solution to a 
monochromatic beam of X-rays where the scattering intensity of radiation is detected as a 
function of scattering angles (figure 1.12). So, this dispersion is dependent on the protein 
concentrations and contrast Δρ (r). The last one is the difference between the electron density 
of the solute and the solvent.73 The dispersion pattern obtained is indicated in the form of a 
curve. From these curves specific parameters which determine the size and general shape of 
protein can be obtained.73, 74  The SAXS is a very useful and an excellent tool to study protein 
complexes in solution or attend important structural differences upon ligand binding.   
 
Figure 1.12 – Representation of SAXS procedure and its data. A: Schematic representation of SAXS. B: 
Data collection by SAXS of BSA protein showing the envelope after the processed data. (adaptation)70, 74 
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1.5. Isothermal Titration Calorimetry 
 
The Isothermal titration calorimetry (ITC) measures directly the energy related with a 
chemical reaction triggered by the mixing of two components. The ITC instruments operate on 
the heat compensation principle, the instrumental response (measured signal) is the amount of 
power (micro calories per second) necessary to maintain constant the temperature difference 
between the reaction and reference cells.75 
So, basically the ITC measures the heat absorbed or produced when molecules 
interact. 76 A typical ITC experiment is carried out by the addition of one of the reactants into the 
reaction cell containing the other reactant (figure 1.13 A). The chemical reaction generated by 
each injection either releases or absorbs a certain amount of heat proportional to the amount of 
ligand that binds to the protein in a particular injection and the characteristic binding enthalpy for 
the reaction. The heat after each injection is consequently obtained by calculating the area 
under each peak. Because the amount of uncomplexed protein available gradually decreases 
after each successive injection, the magnitude of the peaks becomes progressively smaller until 
complete saturation is achieved.75  
Experimentally, the solution with the target biomolecule is placed in the sample cell, and 
a ligand solution in a corresponding buffer is placed in the syringe. When the ligand solution is 
injected into the cell, the ITC instrument detects heat that is released or absorbed as a result of 
the interaction (figure 1.13 B). Injections are performed constantly, and result in peaks that 
become smaller as the biomolecule becomes saturated. After titration is completed, the 
individual peaks are integrated by the instrument software (figure 1.13 C). An appropriate 
binding model is chosen and the isotherm is fitted to yield the binding enthalpy ΔH, the KD, and 
the stoichiometry, n. From these data, Gibb’s free energy, ΔG and entropy, ΔS are calculated.76, 
77 
For the reaction to be measured directly by ITC, the product of the protein concentration 
in the calorimeter cell and the binding constant, a parameter known as c, has to be lower than 
1000. Accordingly with this restriction, the upper limit for the binding constant is between 108–
109 M–1. Further than a certain value, the titrations lose their curvature, becoming 
indistinguishable and it is not possible  to determine the binding constant.75, 78  
 
The key for this problem has been obtained by the design of competition experiments in 
which the high-affinity ligand is titrated into protein that is prebound to a weaker ligand.75 There 
are some characteristics to concern in this type of competition assays; the advantages are: 
experimental conditions are not altered and, therefore, the binding affinity is determined at the 
planned experimental conditions; the thermodynamic stability of the macromolecule is not 
compromised by changing the experimental conditions. On the other hand, the limitations of this 
method are: the binding affinities of the weak ligand and the strong ligand must differ by a factor 
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of 10 or more as well as the binding enthalpies of the weak ligand and the strong ligand should 
be as different as possible, otherwise the measured heat signal will be small.79, 80 
Figure 1.13 – The ITC experiment. A: The ligand titrated into the sample cell. B: An exothermic reaction 
releases heat and gives negative peaks. C: The peaks are integrated and presented in a reported data.76  
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2.  Objectives 
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The main aim of this master thesis is to understand the specific interaction between the 
periplasmic component of ABC transporter systems with their ligands. Previous to this work, 
both ModA and TupA proteins were heterologously produced and purified. Consequently, this 
work focuses on determining the structural and functional characteristics that are responsible for 
the selectivity of proteins ModA and TupA from sulfate-reducing bacteria Desulfovibrio 
alaskensis G20 by molybdate and tungstate, respectively.  
 
To achieve this main subject we point to solve the following specific objectives: 
• Determine the crystallization conditions, X-ray structure and biochemical properties of 
ModA and TupA from Desulfovibrio alaskensis G20 and compare the metal coordination 
in holoproteins. In addition, basic biochemical characterization was necessary to 
determine the quaternary structure and UV-Vis properties;   
• Evaluate the relevance of the highly conserved arginine (R118) in the TupA protein 
putatively involved in the coordination of the oxoanions; 
• Site directed mutagenesis was performed on the positively charged arginine 118 (pI 
10.1) residue. Three residues with different properties were chosen: Lysine (K), 
Glutamate (E) and Glutamine (Q); 
• Study the interaction between each protein and both molybdate and tungstate; 
• Analyze the conformational changes induced by metal-protein interaction.    
Both proteins were previously cloned, heterologously produced in E.coli and purified.  
Although the structure of ModA was determined for several microorganisms, in this work 
we intend to structurally characterize TupA using protein X-ray crystallography. Furthermore, 
and to understand the importance of the highly conserved arginine (R118) putatively involved in 
the coordination of the ligand, site directed mutagenesis is applied. Three different mutants of 
TupA have been design and produced. To help understanding the selectivity of the proteins 
towards metals, biochemical characterization using different techniques is necessary. For a 
qualitative analysis, gel electrophoresis was performed while ITC enabled to quantify the affinity 
of the protein-ligand interaction. Optimization of the crystallization conditions of TupA was also 
carried out for the three variants and for the native protein in the presence of ligands (WO4
2- and 
MoO4
2-). 
Despite the cloning, over-expression and purification conditions had already been 
determined; the biochemical description for ModA using the techniques mentioned above is also 
required. In this work we also intend to crystallize ModA in the presence and absence of both 
ligands for structural characterization.  
Furthermore, conformational changes upon ligand binding are also of utmost 
importance and low resolution models of ModA, TupA and the three mutants of TupA in solution 
can be obtained by SAXS technique.   
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3. Experimental Procedure 
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The genes encoding TupA and ModA proteins were previously cloned in pET vectors, 
the constructs were used to transform E. coli cells (BL21 (DE3)) and the proteins were 
heterologously produced and purified.30 This work was performed in the frame of the project 
“Molecular aspects of sulfate reducing bacteria inhibition by molybdate” (Ref. EXPL/BBB-
BEP/0274/2012, Fundação para a Ciência e a Tecnologia) with Dr. Maria Gabriela Rivas as 
principal investigator. Crystallization assays were carried out in the laboratory of Prof. Maria 
João Romão by Ana Rita Cardoso and Dr. Teresa Santos-Silva. For TupA, a crystallization 
condition could be found where good diffracting crystals were obtained. The crystal structure of 
the protein was solved by Ana Rita Cardoso using the molecular replacement method. 
This Master thesis work starts with the site directed mutagenesis of TupA. 
 
 
 
3.1. Site directed mutagenesis of TupA protein 
 
The tupA gene (locus tag Dde 0234) previously cloned in pET-46 Ek-LIC vector 
(Novagen) was used as template to mutate arginine 118 by PCR using the QuickChange® Site-
Directed Mutagenesis Kit (Stratagene). Briefly, two complementary oligonucleotides containing 
the desired mutations (table 3.1) were designed to each mutation and used to amplify the pET-
46-TupA plasmid. Then the PCR product obtained was incubated with DpnI to digest the 
template (not mutated plasmid) and the product of this reaction was used to transform 
competent cells.  
The amplification reaction was performed on a final volume of 50 µL, using  1µL dNTP 
mix (concentration was not informed in the kit), 1x reaction buffer, 30 ng of the dsDNA template, 
90 ng of each primer (forward and reverse), 2% of DMSO (Merck) and finally 2.5 U of Pfu Turbo 
DNA polymerase. Amplification program was executed on a thermocycler (Bio Rad My 
Cycler™) and included an initial denaturation step at 95ºC for 30 seconds. Then, 18 cycles 
composed by 30 seconds at 95ºC (denaturation) and 60 seconds at 68ºC (primer annealing) 
and 6 minutes at 68ºC (elongation) were performed. The amplified products were analyzed by 
1% agarose gel (NZYTech) electrophoresis in 1X TAE Buffer using GeneRuler™ 1kb DNA 
Ladder (Fermentas) as DNA marker. To each 5 µL of PCR product, 2 µL of 5X sample buffer 
(Fermentas) were added. Electrophoresis was performed at 100 V for 30 minutes in Mini Run 
Ge-100 equipment. PCR products were first stained with SYBR Safe™ DNA gel staining 
(Invitrogen) observed and images captured on GenoSmart gel documentation system (VWR). A 
volume of 1 µL of the DpnI 10U/ µL was added to each amplification reaction to digest the 
parental supercoiled dsDNA. The reaction mixtures were spin down in a microcentrifuge 
(Minispin, Eppendorf) for 60 seconds and immediately incubated at 37ºC for 1 hour.  
After the parental DNA digestion, the reactions were used to transform XL1-Blue 
supercompetent cells (QuickChange® Site-Directed Mutagenesis Kit, Stratagene) and the 
plasmids were isolated from a single colony (grown in Luria-Bertani media with ampicillin 
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(NZYTech, 100 µg/mL)) using the NZY-Tech Miniprep kit (NZY-Tech, Lisbon, Portugal). The 
recombinant plasmids were quantified in a Nanodrop (Thermo Scientific Nanodrop 2000c) and 
sequenced using an ABI3700 DNA analyzer (Perkin/Elmer/Applied Biosystems, Stabvida, 
Caparica, Portugal).The sequences were analyzed and aligned using the online tool: BLASTp81 
and ClustalW.82 
 
Table 3.1 – Primers used to mutate arginine 118 to lysine (R118K), to glutamic acid (R118E) and to 
glutamine (R118Q) 
Primer Sequence 
f-TupA_R118K (sense) CCGTATTTGTAAGCAAGGGCGACAACTCGG 
r- TupA_R118K (antisense) CCGAGTTGTCGCCCTTGCTTACAAATACGG 
f- TupA_R118E (sense) CCGTATTTGTAAGCGAGGGCGACAACTCGG 
r- TupA_R118E (antisense) CCGAGTTGTCGCCCTCGCTTACAAATACGG 
f- TupA_R118Q (sense) CCGTATTTGTAAGCCAGGGCGACAACTCGG 
r- TupA_R118Q (antisense) CCGAGTTGTCGCCCTGGCTTACAAATACGG 
 
 
3.2. Heterologous protein production  
 
The first expression condition tested for the mutants was the one used for the 
recombinant TupA protein, it means Escherichia coli strain BL21 (DE3), transformed with one of 
the mutated plasmids, pET46-tupAR118K, pET46-tupAR118E or pET46-tupAR118Q, grown in 
Luria Bertani (LB) media till an OD600 ≈ 0.4 AU at 37 °C, followed induction with 1mM of 
isopropyl β-D-galactopyranoside (IPTG) (NZYTech) during 3h at 30 °C. Since these expression 
conditions yielded insoluble protein, different expression tests were performed for each mutant. 
Three different expression cells were used, namely, Rosetta2, Origami and Tuner and two 
different temperatures of induction were tested (19 ºC and 30 ºC). In addition, two different 
media, LB and autoinduction (Appendix II) at different concentrations of IPTG (0.1, 0.3, 0.5, 0.8 
and 1 mM) were tested. The optimal condition for expression of each mutant was then used to 
produce the proteins. Note that the expressions tests were done in 10 mL of LB media. 
  TupA_R118K and TupA_R118E mutants were produced in E.coli Rosetta2 and Origami 
cells, respectively. Cells transformed with the plasmids were cultured in Luria-Bertani media 
supplemented with ampicillin (NZYTech, 100 µg/mL) at 180 rpm and 37 ºC. Cells were induced 
when OD600 reached 0.6 AU with 1 mM IPTG (NZYTech) and grown at 19 ºC overnight. The 
TupA_R118Q, construct was used to transform  E.coli Tuner cells cultured in LB media 
containing ampicillin (NZYTech, 100 µg/mL) at 180 rpm and 37º till OD600 =  0.6 AU. The 
induction was performed by addition of 0.3 mM IPTG (NZYTech) and further incubation at 19 ºC 
overnight. All the cells were collected by centrifugation at 8000 rpm for 20 min (JA 10, Beckman 
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Coulter), resuspended in 50 mM sodium phosphate pH 8 (Sigma-Aldrich), 500 mM NaCl 
(Merck) buffer containing 5mM DNase (NZYTech) and 1 tablet of Protease Inhibitor Cocktail 
EDTA free (Sigma-Aldrich) using a ratio of 2 g cells/ mL.  
 
The cells suspensions were broken by sonication (UP100H//Tip MS7/ Hielscher 
Ultrasonics), using a mild protocol where the ultrasounds repeatedly applied (5 times for 3 
minutes with 0.5 cycles and 80% amplitude). Each crude extract was centrifuged at 10 000 rpm 
(F34-6-38, Eppendorf), for 30 min and the soluble fraction was filtered through a 0.45 µm 
membrane (VWR). 
 
3.3. TupA mutants purification  
 
The pET-46 Ek-LIC expression vector encoded a six-histidine tag at the N-terminal 
sequence enabling the purification by immobilized-metal affinity chromatography (IMAC).  A His 
GraviTrap (GE Healthcare) equilibrated with 50 mM sodium phosphate pH 8 (Sigma-Aldrich), 
500 mM NaCl (Merck) was used to inject the crude extract. Before injection the sample was 
dialyzed against the equilibration buffer. The proteins fractions were eluted with a step gradient 
of 20 mM, 50 mM, 100 mM and 250 mM imidazole (Sigma-Aldrich). The fractions containing the 
TupA mutants were identified by 10% SDS-PAGE (Tris-Tricine) and the gels were stained using 
Coomassie brilliant blue solution. The pure fractions containing the TupA_R118K, TupA_R118E 
and TupA_R118Q were pooled together and dialyzed against 5 mM Tris-HCl pH 7.6. The 
samples were concentrated using ultrafiltration devices (VIVASPIN TURBO 15. 10000 MWCO, 
Sartorius Stedim Biotech) and stored at -20 ºC until further use. All of the steps, including cell 
collection, soluble extracts preparation and purifications, were performed at 4 ºC. 
 
3.4. Biochemical characterization of TupA and ModA 
 
3.4.1. Extinction Coefficient Determination 
 
The extinction coefficient (Ɛ) for TupA and ModA had already been previously 
determined, corresponding, respectively, to 29700 M-1cm-1 and 22500 M-1cm-1 at the 280 nm 
absorption peak. These values are in good agreement with the values deduced from the amino 
acid sequence of pure protein (30440 M-1cm-1 and 23295 M-1cm-1, respectively).30 Nevertheless, 
the extinction coefficient of each TupA mutant was experimentally determined. 
The concentration of the three mutants (TupA_R118K, TupA_R118E and 
TupA_R118Q) was determined by Bradford83 using bovine serum albumin (0, 0.1, 0.15, 0.2, 
0.25 and 0.3 mg/mL) as standard. Then, five different dilutions of each TupA mutant were 
performed and the absorbance at 280 nm was measured. The extinction coefficient was 
obtained from the slop of the absorbance at 280 nm vs protein concentration curve. The UV-
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visible absorptions were measured in an Evolution 201 (Thermo Scientific) split beam 
spectrophotometer using 1 cm optical path cells. The values obtained were different from those 
determined using the bioinformatics tool, from JustBio.84  
 
3.4.2. Protein Gel Shift Assay 
 
TupA, ModA, TupA_R118K, TupA_R118E and TupA_R118Q protein samples (50 µM) 
were incubated with 500 µM of MoO4
2− (Sigma-Aldrich) or WO4
2−anions (Sigma-Aldrich) at room 
temperature for 25 min. Unbound anions were separated from each mutant with a PD Mini Trap 
G-25 desalting columns (GE Healthcare) following the manufacturer’s instructions.30, 85 The 
buffer used is the same where the proteins were stored: 5 mM Tris-HCl (pH7.6) 
The electrophoresis was carried out at 120 V constant for 1h30min on a native 10% 
polyacrylamide gel with 1X of loading buffer (Appendix III). The mobility shift assay was 
analyzed after staining the gel with Coomassie Brilliant Blue solution. 
 
3.4.3. Urea-polyacrylamide gel electrophoresis 
 
The putative conformational changes upon metal ligand binding was analyzed for TupA 
and ModA by urea gel electrophoresis using the Novex 6% tris(hydroxymethyl) aminomethane 
(Tris)-borate (TBE)-urea minigels and a XCell SureLock™ Mini-Cell (Invitrogen).  5 µL of each 
sample mixed with 5 µL of 2x Novex sample buffer (without EDTA) were loaded in the gel. The 
electrophoresis was carried out for 2h30 min at 180 V and 40 mA. The proteins bands were 
examined by staining with Coomassie Brilliant Blue.30, 86 
 
3.4.4.  The Isothermal Titration Calorimetry 
 
The isothermal titration calorimetry experiments were previously executed for TupA and 
ModA. The conditions described below (already optimized) were the same for the studies of the 
TupA, ModA and the mutated proteins.  
The ITC experiments were performed using a VP-ITC calorimeter (MicroCal, GE 
Healthcare). The binding protein (10 µM) was equilibrated in reaction buffer at 30 °C in the cell 
of the calorimeter, and subsequently, 25 injections of 10 µL of a 100 µM sodium tungstate 
(Sigma-Aldrich) or molybdate (Sigma-Aldrich) solution were performed and the heat response 
recorded. Once subtraction of the baseline, the integrated heat responses were fitted to the 
single binding site model using the ORIGIN software package provided with the calorimeter.30  
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3.5. Crystallization Studies 
 
All the crystals obtained were observed in a microscope (Discovery V.12, Zeiss) and 
posteriorly stabilized with a solution of harvesting buffer (similar to the crystallization solution but 
where the concentration of precipitating agent is about 2% superior) and then they are 
transferred to a cyoprotectant solution which can be paratone (Hampton Research) or the 
harvesting buffer with 20-30% of glycerol (Sigma-Aldrich). Crystals were fished, frozen in liquid 
nitrogen and subsequently analyzed by synchrotron radiation.  
 
3.5.1. TupA 
 
TupA crystallized in only one condition of the in-house screen87 containing 0.2 M 
magnesium chloride (Sigma-Aldrich), 0.1 M HEPES (pH 7.5) (Sigma-Aldrich) and 30% (w/v) 
polyethylene glycol 3350 (Sigma-Aldrich). Transparent plate-shaped crystals appeared in 4 
days.30 The crystallization was performed at 20 °C using the sitting-drop vapor diffusion method, 
with 1 µL of protein (7.5 mg/mL plus 1 µL of precipitant solution) on 24-well crystallization plate 
(XRL Molecular Dimensions) with 700 µL of precipitant agent in reservoir.30 
These crystals were used for data collection at beamline ID23-1 at the European 
Synchrotron Radiation Facility (ESRF, France) and the crystal diffracted up to 1.43 Å.30 
 
3.5.2. ModA 
 
The first crystallization studies were performed at 20ºC using the sitting-drop vapor 
diffusion method, with 0.5 µL of protein plus 0.5 µL of precipitant solution on 96-well 
crystallization plates (SWISSCI 'MRC' 2-Drop Crystallization Plates, Douglas Instruments). 
Different commercial screens were tested, namely, Midas (Molecular Dimensions), JCSG ( 
Molecular Dimensions), an 80 conditions in-house screen (based on the screen of Jancarik et 
al)87 and EWI/EWII (Hampton Research). Needle shaped crystals appeared in one condition of 
the in-house screen using (30% (w/v) polyethylene glycol 6000 (Sigma-Aldrich), 0.1M sodium 
cacodylate (pH 6.5) (Sigma), 0.2M ammonium sulfate (Panreac).  
In order to obtain good crystals the precipitant concentration was optimized to 28% 
(w/v) and furthermore, an additive screen was tested (Additive Screen 1 from Hampton 
Research), at 20ºC using the hanging-drop vapor diffusion method. Crystals of ModA (at 
10mg/mL) appeared in hanging-drops with 1 µL of protein plus 0.8 µL of precipitant solution and 
0.2 µL of 20% (w/v) Benzamidine hydrochloride (Hampton Research) on a 24-well crystallization 
plate (XRL Molecular Dimensions) with 700 µL of precipitant solution in reservoir. The colorless 
crystals appeared within 5-6 days.  
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Using the synchrotron radiation, all the crystals obtained were tested. The needle 
shaped crystals diffracted up to 3.5 Å resolution and a complete dataset was collected at 
beamline ID23-1 at the European Synchrotron Radiation Facility (ESRF, Grenoble, France).The 
larger crystals obtained in the presence of the additive diffracted up to 2.77 Å resolution and 
were used to collect a complete dataset at beamline ID I03 at Diamond Light Source (DLS, 
England). 
  
3.5.3. TupA_R118K, TupA_R118E and TupA_R118Q 
 
The first crystallization test was performed at 20 °C using the sitting-drop vapor diffusion 
method, with 0.5 µL of protein plus 0.5 µL of precipitant solution on 96-well crystallization plates 
(SWISSCI 'MRC' 2-Drop Crystallization Plates, Douglas Instruments). Different commercial 
screens were used, namely the EWI/EWII (Hampton Research) and the in-house screen (based 
on the screen of Jancarik et al)87.  
Both mutants crystallized in the same condition of the in-house screen containing 0.1 M 
magnesium chloride (Sigma-Aldrich), 0.1 M MES (pH 6.5) (Sigma-Aldrich)and 30% (w/v) 
polyethylene glycol 8000 (Sigma-Aldrich) on a 24-well crystallization plate (XRL Molecular 
Dimensions). Transparent plate-shaped crystals appeared after 3 days of crystallization set-ups. 
Scale-up and optimization experiments were performed and new crystals appeared in 
hanging-drops with 1 µL of protein (TupR118K (14 mg/mL), TupR118E, (10 mg/mL) or 
TupR188Q (11 mg/mL) plus 1 µL of precipitant solution on a 24-well crystallization plate (XRL 
Molecular Dimensions) with 700 µL of precipitant solution in reservoir. These crystals were also 
used for data collection at beamline ID I03 at the Diamond Light Source (DLS, England). 
However the crystals didn’t diffract. 
 
3.6. Small Angle X-ray scattering 
 
SAXS was performed for ModA in the absence and presence of ligands (MoO4
2− and 
WO4
2−).  
In order to study  the influence of the ligands, the protein solutions were incubated with 
MoO4
2− and WO4
2−anions (Sigma-Aldrich) (1:10) at room temperature for 25 min. Unbound 
anions were separated with a PD Mini Trap G-25 desalting columns (GE Healthcare) following 
the manufacturer’s instructions. The buffer used is the same where the proteins were stored: 5 
mM Tris-HCl (pH7.6). The protein-ligand solutions were to a final concentration of 21, 23 and 20 
mg/mL for ModA, ModA+Mo and ModaA+W, respectively. 
For each sample, 5 serial dilutions were used for scattering measurements. The 
experiment was carried out using synchrotron radiation at the beamline ID BM29 at the 
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European Synchrotron Radiation Facility (ESRF, Grenoble, France). The data collected was 
analyzed using the ATSAS88 tool and PyMOL.89 
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4. Results and Discussion 
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4.1. Primary sequence analysis of TupA and ModA 
 
The genome of all the Desulfovibrio species published to date encodes a tungstate ABC 
uptake systems belonging to the Tup family of proteins. Regarding the 3D structure of TupA 
proteins, two structures from Geobacter sulfurreducens and Eubacterium acidaminophilum were 
announced in the last years and the structure of Gs is available in the protein data bank (PDB 
code 3LR1). The TTTS motif is the signature of TupA proteins where Thr9 and Ser11 (G. 
sulfurreducens numbering) are suggested as residues able to bind the oxoanion through 
hydrogen bonds. In addition, the Thr124 and the positively charged Arg118 (both highly 
conserved in the primary sequences analyzed, figure 4.1) could bind the oxoanion also by 
hydrogen bonds. Arg118 is suggested as the structural element that gives the high selectivity of 
the TupA proteins. The DaG20 TupA contains all the conserved residues putatively involved in 
the oxoanion coordination (figure 4.1).18, 26, 30  
Regarding to ModA proteins from Desulfovibrio species, multiple sequences alignment 
(figure 4.2.) were analyzed, showing that Ser12 (E. coli numbering) is conserved, interacting 
with the oxygen of MoO4
2- through the amine group. At position 152 isoleucines and valines, are 
found, both capable of binding molybdate. In addition, the conserved Tyr170 is sometimes 
replaced by an Ala, probably coordinating molybdate through an H-bond.18, 26, 90 In fact, the 
alignment shows that Ec ModA from strain K12 is also very similar to the corresponding sulfate 
reducing bacteria. 
In order to study the oxoanion coordination by TupA and the relevance of arginine 118 
in the selectivity process, this residue was mutated to lysine (a basic and also positively 
charged amino acid), glutamic acid (an acidic and negatively charged residue) and glutamine (a 
polar neutral amino acid that can form hydrogen bonds). 
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                     10        20        30        40        50        60        70        80        90       100 
                      |         |         |         |         |         |         |         |         |         | 
Dde_0234     -MR--KLLLVLALVMSLTG-VAYAEAPVLMMATTTSTDNTGLLDDLAPQFTKDTGIELRWTAVGTGKALKMGENCDVDILLVHAPAAEKAFVDAGFGTAR 
DVU0745      -MR--RLLFLTCLLAAVISSSAFAADKVLMMATTTSTADTGLLDYLAPLFQKDTGIEVKWTAVGTGKALEMGKNCDVDVLLVHSPSAEAKFIEAGSGIER 
Desal_2876   -MKKLKVLLLTFALVSLLVAPGLVKAETLMMATTTSTDNTGLLDELAPKFQKETGIELKWTAVGTGKALKMGQNCDVDVLMVHAPAAEKKNVDMGALKDR 
Cj1540       -MK----KIISLALALALS----ASAAELKMATTTSTDNTGLLDALKPLYEKESGNTLKWVAVGTGAALKMGEDCNADVLFVHSPKAEKEFMKKGFGVDR 
Ddes_1778    MFRMSRLFLAACVMGLLALAPVARAADVLMMATTTSTQDSGLLEYLEPFFKKETGMELKWVAVGTGKALEIAKNCDADVLLVHAPAAELEFIKAGHGTDR 
GSU2700      -MKMYR-SFAATLVALLMLVTVAGAEERLKMSTTTSTQDSGLLKVLLPPFEKKNNVKVDVIAVGTGQALKLGEAGDVDVVFVHARKLEDKFVADGFGVNR 
              ::     :    :              * *:***** ::***. * * : *...  :   ***** **::.:  :.*:::**:   *   :  *    * 
 
                    110       120       130       140       150       160       170       180       190       200 
                      |         |         |         |         |         |         |         |         |         | 
Dde_0234     TQLMYNDFVIIGPAADPAGVK-GMTVAAALGRIAADNAVFVSRGDNSGTHKMEKSLWKQIEGSSPEKEAWYVQTGQGMLRTINVAAEKGGYTMTDRGTYI 
DVU0745      TQLMYNDFVLVGPVADAAKAA-GKSVDAALKGIAAAKSPFLSRGDKSGTHNLEVKLWEKS-GMAPDKESWYVSTGQGMLRTIAMAAEMGGYTVTDRGTWI 
Desal_2876   REVMYNDFVIIGPDSDPAGIK-GLPVVQAMKAVADAKAAFVSRGDNSGTNKKEISLWKVAGMAVPDKAEWYIQTGQGMIKSITVAEERDAYIMTDRGTYI 
Cj1540       TPVMYNDFIIIADKSLASKFK-GKNLKESLELIKNEKLTFISRGDKSGTDNKEKSLWKNL-GGVPEKQSWYQQSGQGMLASIKIAEEKKGVILTDRGTYI 
Ddes_1778    RQIMYNDFVIVGPKADPAKIA-GKSSAEALGRILKSKAGFVSRGDQSGTHKAEQKLWQQA-GITPDKDPAYFSAGQGMMATLNMAAEKKAYALTDRGTWI 
GSU2700      KDVMYNDFVIVGPKNDPAGIAKAKTAAEALKLLATKGATFISRGDKSGTHTKELDLWKSA--GVDPKGNWYVEAGQGMGPVITMATERRAYTLTDRGTYN 
               :*****:::.    .:    .     ::  :      *:****:***.. * .**:        *   * .:****   : :* *  .  :*****:  
                    210       220       230       240       250       260       270       280 
                      |         |         |         |         |         |         |         | 
Dde_0234     KYEASMDGNPPLKILVEGDKILFNQYSAIPVNPAHCPKVKKDLADKFVNWMASPATQKTIGDFKLMGKALFTPNAE---- 
DVU0745      KYESTLNGAPVLKIIVEGDKSLLNQYSGIVVNPAQCPKVKADLAREYIKWMASPAGQKYIGDFLVSGKPLFTPNAGK--- 
Desal_2876   KYSANKNGSPELKVLVEGDKSLFNQYSVLAVNPANCKNAKYELATKFSEWMASPSTQKAIGDFKLLGKKLFIPNAK---- 
Cj1540       KYEANEKGKPNLVIVNEGDDSLKNFYSVIATNPKHCKNVNYTEASKFIKWVTSDKTLNFIADFKLLNKPLFVIDAKTRKD 
Ddes_1778    TFADKAGADNPLAIAMEGDTALFNQYSVITVNPDRCPKVDKALAQKFEDWWVSPSTQQKIADYKLKGKQLFFPNAGK--- 
GSU2700      AFKG---AKTDLVILFQGEKGLFNPYGIMAVNPKKFPHVKYDLAMKLIDYVTGPEGLKIISDYKAHGEPVFFIYKK---- 
              :     .   * :  :*:  * * *. : .** .  :..   * :  .: ..    : *.*:   .: :*                              
 
Figure 4.1 - Multiple sequence alignment of TupA proteins. Dde_0234, D. alaskensis G20; DVU0745, 
D.vulgaris Hildenborough; Dde_2876, D.salexigens; Cj1540, C. jejuni strain NCTC 11168; Dde_1778, 
D.desulfuricans ATCC 27774; GSU2700, G.sulfurreducens. Residues putatively involved in the coordination 
of tungstate are highlighted in black. Symbols: (*) identity, (:) strongly similar and (.) weakly similar.30 
 
 
                     10        20        30        40        50        60        70        80        90       100 
                      |         |         |         |         |         |         |         |         |         | 
Ec K12       DEGKITVFAAASLTNAMQ-DIATQFKKEK-GVDVVSSFASSSTLARQIEAGAPADLFISADQKWMDYAVDKKAIDTATRQTLLGNSLVVVAPKASVQKDF 
Daes         --ADLLIAQAANFTSIMQDEIIPAFEKAT-GLTVQATYASTGKLYGQIVNDAPFDMLLAADESRPDKLYADGLAQKP--FVYAQGQVVFWSLDTKLCAQG 
Dal G20      --QDLLVAQAANFMPAME-EILPAFEAAT-GIKGHAVYSSTGKLYAQISNGAPFDVFLAADEARPAKLAAEGKSEAP--FVYARGKVVLWLPQPGVTAAD 
Dd 27774     --AEMTVSGAASLTNAFT-ELKDMFEKQHPGLKVNVNFAASNPLLKQIQEGAPVDVFASADQATMDKAAAAKVVDPATRKNFAENDLVLIVPAGS-KKPA 
DmR          --GDITVSAAASLTDAFN-EIKGVFTKDHPGVNVTFNFAASGALLSQMAQGAPVDVFASADQKTMDQAVEKKLVDVPTRVNFVQNALVMAVPADNPAKLK 
Ds           --ADLMIAQAANFMPAMK-EIIPAFKKAS-GLEVQATYTSTGKLYAQIVNGAPFDLFLAADERRPQKLFNDGLTETP--FVYAKGKVVLWSKDKKNIGNS 
DvH          --GNITVSAAASLTNAFT-ELKTLFEKKT-GDTVTTNFAASNPLLRQMQEGAPVDVFASADQETMDKAAAGGLVDKATRKDFATNGLVLIVPAASTLKIA 
                .: :  **.:   :  ::   *     *      ::::. *  *:  .** *:: :**:            : .       . :*.            
 
                    110       120       130       140       150       160       170       180       190       200 
                      |         |         |         |         |         |         |         |         |         | 
Ec K12       TIDSKTNWTSLLNGGRLAVGDPEHVPAGIYAKEALQKLGAWDTLSPKLAPAEDVRGALALVERNEAPLGIVYGSDAVASKG-VKVVATFPEDSHKKVEYP 
Daes         WKAALQDP----AVKKIAIANTETAPYGTSAMKALQAAGIWDAVQPRLVFGQSISQVFQFASSGAADVGFIAYSSIFTEEGKKGCFVVVD--EAPPVVQA 
Dal G20      WQQCLQRD----TIQRIAVANPESAPYGAAAVAALNKAGLFETVSPRLAYAQSIAQVFQFASSGAADAGFCALSSTLTEQGRTGTTFAVP--QAPSVIQA 
Dd 27774     ALADLK------KFKKVAIGNPDSVPVGRYTKAALTDAKLWDAMQPALIQGNSVRQVLDYVARGEVDAGFVYATDARQMADKVDVVMVVG--GHEPVTYP 
DmR          DLTNLTAP----AVKRIAVGNPDSVPVGRYTKAALTKTGLWDAISGKFVLAESVRQVLDYLSRGEVDAGFVYATDAKQGGDKVKTILEVP--VETPVTYP 
Ds           WQETIKAG----KLNKIAIANTETAPYGTAAMIALQHAKLWEQVKPELVYAQSIAQAFQFASTGAADAGFCAYSSMFTPTGKKGRFAVVK--EAPPVIQA 
DvH          AASDLKAA----EVRHIAVGNPDSVPAGRYARAALTAAGLWETLTPKLIVAESVRQALDYVARGEVDAGFVYATDAAIARDKVRVAATMT--GHKPVSYP 
                            ::*:.:.: .* *  :  **     :: :   :  .:.:  .:     . .  *:   :.     .       .       *  . 
 
                    210       220       230 
                      |         |         | 
Ec K12       VAVVEGHNN-ATVKAFYDYLKGPQAAEIFKRYGFTIK 
Daes         GCILKKAPNPEAAARFAEFLASPEVQAMKLKYGYK-- 
Dal G20      ACILKSAPNPQAAARFVEFLNSPLVAEIKAKYGYE-- 
Dd 27774     IAVALTGTNPKMGQEFLNFVLSPEGLAVLAKYGFSKP 
DmR          IAVLEAAKDKKDAAAFVAFVTGSKGQAILAKYGFKKP 
Ds           ACILKSSEHKIAAIKFVEFLSGPEATAIKKKYGYD-- 
DvH          IAVATAARDAETAKRFVAFVLSPEGQAVLARYGFGKP 
              .:     .      *  :: ..    :  :**:      
 
 
Figure 4.2 - Multiple primary sequence alignment of ModA proteins. E. coli K12 (Ec K12, locus tag b0763), 
D.aespoeensis (Daes, locus tag Daes 2623), D.alaskensis G20 (Dal G20, locus tag Dde 3518), 
D.desulfuricans ATCC 27774 (Dd 27774, locus tag Dde 0168), D.magneticus RS-1 (DmR, locus tag DMR 
17460), D.salexigens (Desal, locus tag Dde 3518) and D.vulgaris Hildenborough (DvH, locus tag 
DVU0177). Residues involved in coordination of molybdate are highlighted in black. Symbols: (*) identity, 
(:) strongly similar, (.) weakly similar. 
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6000 bp -  
  M              1 
6000 bp -  
  M                 2              3 
4.2. Site directed mutagenesis of TupA and optimization of the mutants expression 
 
As mentioned in section 3.1., the tupA gene was previously cloned in pET-46 Ek-LIC 
vector (Appendix IV) and the construct was used as template to mutate Arg118 by PCR. The 
vector pET46-TupA was used to clone each mutant using two complementary oligonucleotides 
(primers) containing the desired mutation (R118K, R118E and R118Q).The PCR products 
obtained were electrophoresed in agarose gels to confirm the amplification (figure 4.3) and the 
non-mutated DNA was digested by DpnI. The digestion reaction was used to transform 
competent cells, the mutant plasmids were isolated from a single colony by miniprep and the 
mutation was confirmed by sequencing the obtained tupA gene. 
 
 
 
 
 
 
 
 
Figure 4.3 – 1% agarose Gel electrophoresis of the PCR product obtained (before DpnI digestion). M: 
Marker; 1:TupA_R118K; 2: DNA of TupA_R118E and 3: DNA of TupA_R118Q. The size of the fragment 
(6000 bp) is in line with the expected value, it means, the vector (5200 bp) plus and the tupA gene (756 
bp). 
The first condition tested for the expression of TupA mutants was  the one used for the 
recombinant TupA protein30, however the three mutants were produced in insoluble forms 
(Appendix V). Therefore, several expression conditions were tested including four different 
E.coli strains (BL21, Rosetta2, Origami and Tuner), two culture media with different composition 
(LB and autoinduction) and different induction conditions (at 19ºC and 30ºC using several IPTG 
concentrations). The expression of the mutants was evaluated by SDS-PAGE. 
As shown in figure 4.4 each mutant is produced under different conditions. 
TupA_R118K mutant can be expressed by Rosetta2 and TupA_R118E by Origami cells, both 
induced with 1mM of IPTG. In the case of TupA_R118Q, the best expression condition was 
found using Tuner cells induced with 300 µM IPTG. In all the cases, cells were grown in LB 
medium and proteins were induced overnight at 19 ºC.  
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Figure 4.4 - Expression of TupA mutants evaluated by electrophoresis in polyacrylamide gels (12.5%) 
under denaturing conditions (SDS-PAGE), stained with coomassie brilliant blue: M) molecular weight 
markers; (1) Soluble protein fraction of cells transformed with the pET46-TupA_R118K vector; (2) Insoluble 
protein fraction of cells transformed with the pET46- TupA_R118K vector; (3) soluble protein fraction of 
cells transformed with the pET46- TupA_R118E vector, (4) insoluble protein fraction of cells transformed 
with the pET46- TupA_R118E vector (5) the insoluble protein fraction of TupA_R118Q vector and (6) 
soluble protein fraction of cells transformed with the pET46- TupA_R118Q vector.  
 
The migration of the recombinant TupA protein correspond to approximately 35 kDa  
which is in  agreement with the expected size of the protein (29 kDa –TupA- plus 1 kDa -His6-
tag- and 2 kDa -signal peptide-). Although the mutant proteins are produced in both soluble and 
insoluble fractions (figure 4.4), the amount in the soluble fraction was enough to perform the 
studies proposed in this work. The production yield obtained was around 12 mg of 
TupA_R118K, 13 mg of TupA_R118E and 35 mg of TupA_R118Q per liter of cell culture. 
 
4.3. Purification of TupA mutants 
 
The purification of recombinant TupA includes two steps: an anionic exchange and a 
size exclusion chromatography. TupA elutes from the anionic exchange resin at approximately 200 
mM Tris–HCl (pH 7.6), which is in agreement with the isoelectric point calculated for the protein 
(pI 5.69) by the bioinformatics JustBio tool.84 This purification protocol was tested for the three 
mutants but with unsuccessful results (Appendix VI). Instead, an immobilized metal ion affinity 
chromatography was performed (IMAC) using a Ni-NTA resin.  
The three mutated proteins and the recombinant TupA have a His6-tag, however only 
the mutants showed affinity for the Ni-NTA resin .Therefore, the three mutants were suspended 
in 50 mM sodium phosphate (pH 8) plus 500 mM NaCl and a gradient of 50-250 mM imidazole 
was used in order to differentially elute mutants and contaminants (SDS-PAGE of the eluted 
fractions shown in figure 4.5). After this step, imidazole was immediately removed by dialysis 
using 5 mM Tris–HCl (pH 7.6) buffer.  
  M            1          2 M            5          6 M           3        4 
75 kDa – 
63 kDa – 
48 kDa – 
 
35 kDa – 
 25 kDa – 
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Figure 4.5 - Purification of TupA mutants evaluated by SDS-PAGE (12.5%), stained with coomassie 
brilliant blue: (M) molecular weight markers; 1) Soluble fraction of cells transformed with pET- 
TupA_R118K vector; (2 to  7 correspond to TupA_R118K mutant) 2) Flow through; 3) Washing step; 4) 
Elution with 20 mM imidazole; 5) Elution with 50 mM imidazole; 6) Elution with 100 mM imidazole; 7) 
Elution with 250 mM imidazole; (8 to 13 correspond to TupA_R118E mutant) 8) Flow through; 9) Washing 
step; 10) Elution with 20 mM imidazole; 11) Elution with 50 mM imidazole; 12) Elution with 100 mM 
imidazole; 13) Elution with 250 mM imidazole; (14 to 20 correspond to TupA_R118Q mutant) 14) Soluble 
fraction of cells transformed with pET- TupA_R118Q vector; 15) Flow through; 16) Washing step; 17) 
Elution with 20 mM imidazole; 18) Elution with 50 mM imidazole; 19) Elution with 100 mM imidazole; 20) 
Elution with 250 mM imidazole. 
As shown in figure 4.5, during the first step of purification the resin was probably 
saturated with the sample and the protein was diffuse along the fractions. 
  
TupA_R118K TupA_R118E 
 M        1          2       3        4        5        6        7            M        8         9        10       11      12       13        
TupA_R118Q 
75 kDa – 
63 kDa – 
 48 kDa – 
 
35 kDa – 
25 kDa – 
 
11 kDa – 
   M       14        15       16        17       18       19        20       
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4.4.  Biochemical characterization 
 
4.4.1. Extinction Coefficient Determination 
 
As mention in section 3.4.1 the extinction coefficient at 280 nm (Ɛ280) of TupA and ModA 
were already determined showing values of 29.7 mM-1cm-1 and 22.5 mM-1cm-1, respectively. 
Using the bioinformatics tool, JustBio84, it was found 30.44 mM-1cm-1 as the Ɛ280 value for the 
three mutated proteins.  
Experimentally, the Ɛ280 was calculated by determining the mutant concentration using 
BSA as standard. After that, a new calibration curve was performed with different dilutions of 
each mutant. The extinction coefficient at 280 nm was determined from the slope of the curve 
obtained by linear regression of the absorbance at 280 nm versus protein concentration 
(Appendix VII). The Ɛ280 for TupA_R118K, TupAR118_E and TupAR118_Q were 32 ±1 mM
-1cm-
1, 27 ±1 mM-1cm-1 and 24 ±1 mM-1cm-1, respectively. Despite the differences between the 
experimental Ɛ280 values, they are in good agreement with the theoretical ones. 
 
4.4.2.  Protein Gel Shift Assay 
 
Sequence analysis suggests that DaG20 TupA is a tungstate-binding protein that is able 
to bind tungstate as well as molybdate ions.18 To test the affinity and specificity of the three 
mutants as well as ModA with the two different anions, native polyacrylamide gel 
electrophoresis of protein samples pre-incubated with MoO4
2− and WO4
2− was carried out as 
described in section 3.4.2. The samples were submitted to a size-exclusion PD-10 minitrap G-
25 column prior to loading on native polyacrylamide gel in order to separate the unbound ions 
and ensure that differences in mobility were only due to binding anions to the proteins.  
 
As seen in figure 4.6, TupA can bind both metals since a mobility shift is observed for 
the protein incubated with the metals when compared to the free form. In the case of the 
mutants, only TupA_R118K showed a mobility difference upon binding tungstate. This result 
evidences the importance of a positively charged residue like arginine at this position for the 
coordination of WO4
2− oxoanion and that this residue can be only replaced by another with 
similar characteristics, as is the case of lysine. For ModA, the native gel shows that the protein 
has comparable affinity for both metals, similar to TupA 
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Figure 4.6 - Ligand-dependent mobility shift assays for the three mutated proteins in the presence of two 
different oxoanions (10-fold excess); (M): BSA protein as control, (1): TupA, (2): TupA+MoO4
2−; (3): 
TupA+WO4
2−; (4) TupA_R118K, (5): TupA_R118K+MoO4
2−, (6): TupA_R118K+ WO4
2−, (7): TupA_R118E; 
(8):  TupA_R118E+WO4
2−; (9): TupA_R118E+MoO4
2−, (10): TupA_R118Q; (11): TupA_R118Q+MoO4
2−, 
(12): TupA_R118Q+ WO4
2−, (13): ModA, (14): ModA+ MoO4
2− and (15): ModA+ WO4
2− 
 
4.4.3. Denaturation pattern of recombinant ModA, TupA and mutants evaluated by Urea-
polyacrylamide gel electrophoresis 
 
Urea-polyacrylamide gel electrophoresis studies have been used before to evaluate the 
interaction between the transferrin (hTF) transport system and Fe3+. In this system it was 
observed that when iron is bound, each domain rearranges to form the closed conformation. 
Correspondingly, upon release of iron, the metal-binding domains move apart. In the closed 
form, hTF can be recognized by the hTF-cell receptors and iron is internalized by the cell.86 In 
the apo (open) form, hTF has a moderate gel migration, opposite to the holo protein (closed 
conformation) which migrates very extensively in the gel. In general, migration through these 
gels is influenced by the pH, time and temperature of the experiment together with shape, size 
and charge. 
  
 M         1         2        3         4        5         6                   M         1         2          3        7         8         9          
1       2      3      10     11    12    M    13     14     15                
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       1    2     3     4      5     6    7    8    9    10   11    12   13    14   15  
Analogously, the influence of the ligands (molybdate and tungstate) on both proteins 
(TupA and ModA) was studied by this technique since conformational changes are expected 
upon ligand binding. To determine the effect of molybdate and tungstate binding on the 
conformation of each mutant as well as the wild type protein, gel electrophoresis experiments 
were carried out using a TBE Urea gel system. To ensure that all the protein molecules interact 
with metal oxoanions, samples were prepared using a 10-fold excess of metal and the unbound 
metal was then separated by size exclusion chromatography. Figure 4.7 shows the migration 
pattern of samples prepared in the presence and absence of ligands. 
  
  
 
 
 
 
 
 
 
 
Figure 4.7 - Urea polyacrylamide gel electrophoresis of samples containing (1): TupA, (2): TupA+MoO4
2−; 
(3): TupA+WO4
2−; (4) TupA_R118K, (5): TupA_R118K+MoO42−, (6): TupA_R118K+ WO42−, (7): 
TupA_R118E; (8):  TupA_R118E+MoO42−; (9): TupA_R118E+WO42−, (10): TupA_R118Q; (11): 
TupA_R118Q+MoO42− and (12): TupA_R118Q+ WO42-, (13): ModA, (14): ModA+ MoO42− and (15): ModA+ 
WO4
2-. All samples applied to the gel except (1), (4), (7),(10) and (13) were first passed through a size-
exclusion PD-10 minitrap G-25 columns to eliminate the excess of ligand. 
Analysis of the gel suggests that TupA+WO4
2-, ModA+WO4
2- and ModA+MoO4
2- adopt a 
very compact structure migrating further than the other samples under increasing denaturing 
conditions. Accordingly, wild type TupA, TupA_R118K, TupA_R118Q and ModA are probably in 
the open form and denature more rapidly in the 6M urea gradient. The same results are 
obtained for two of the mutants, in the presence of molybdate or tungstate (TupA_R118K+ 
MoO4
2- , TupA_R118K+ WO4
2-, TupA_R118Q+ WO4
2- and TupA_R118Q+ MoO4
2-). The reason 
for this is probably because none of the metals bound tightly to these proteins, which were in 
the open form. The results obtained for the TupA_R118E mutant also indicate that in the 
presence or absence of any of the metals, the protein is in the open form. The fact that this 
mutated protein samples migrate a little further than the others might be due to charge effects 
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and not ligand binding. The results support the major role of arginine 118 in metal coordination, 
also observed by native gel analysis. 
In order to quantify the protein metal interaction, isothermal titration calorimetry (ITC) 
binding studies were performed.  
 
4.4.4. The Isothermal Titration Calorimetry 
 
ITC is a sensitive method to determine affinity/dissociation constants for protein-ligand 
binding, namely, tungstate and molybdate to the corresponding transporting proteins, TupA and 
ModA, in nanomolar and subnanomolar ranges.1, 30 This technique has the advantage that 
nearly all interactions create a heat change that can be monitored with a high-sensitivity 
calorimeter, allowing the determination of the binding enthalpy (ΔHobs) and dissociation 
constant.91 It was reported by Otrelo-Cardoso et al that the observed behavior of TupA at 30 °C 
is consistent with an exothermic process, with a single binding site model. However, the thigh 
nature of these bindings precluded an accurate fit to determine the KD values. 
30 In this work we 
performed displacement titrations in order to obtain the correct affinity constants. ITC of TupA 
and ModA showed that the proteins exothermically bind tungstate and molybdate; however the 
TupA_R118K only binds exothermically tungstate. The TupA_R118E and TupA_R118Q 
mutants are not able to bind either tungstate or molybdate.  
Figure 4.8 and table 4.1 show the ITC data collected for TupA with an exothermic 
interaction between the protein and the metals and a 1:1 stoichiometry, as deduced from the 
heat release upon addition of tungstate or molybdate to the protein solution. Direct titration of 
molybdate against TupA produced an exothermic binding with a KD value of 6.1 ± 0.9 nM. The 
value of ΔHobs (~6.6 kcal/mole of injectant) is also significantly less favorable when compared 
with the tungstate binding. In contrast the binding of tungstate to TupA is much more exothermic  
with ΔHobs being increased to ~14 kcal/mole of injectant.
30  
To determine a KD value for tungstate a binding competition strategy was adopted. A 
displacement titration of the molybdate-saturated protein with tungstate clearly showed that the 
protein favors the binding of tungstate even when the binding site is occupied with a molybdate 
molecule. The apparent binding constant depends on the concentration of free molybdate which 
was 0.5 mM, and therefore KD for tungstate was determined to be 6.30 ± 0.02 pM (figure 4.8 C, 
Table 4.1) when the protein is saturated with molybdate. The displacement titration and the 
particularly low KD value for tungstate indicate that the latter should be the physiological 
substrate of TupA as expected.18, 30 
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Table 4.1 - Data for the ITC analysis of oxoanion binding to TupA protein at 30 °C 
Protein (+oxoanion) Ligand N KA (M
−1
) KD (nM) ∆H (kcalmol
−1
) 
 
TupA 
 
WO4
2− 
 
0.842±0.001 
 
2 × 109 ± 2 × 109 
 
0.5 ± 0.5 
 
−13.500±0.005 
MoO4
2− 0.868±0.002 16×107 ± 2 × 107 6.3 ± 0.8 −6.600 ± 0.003 
TupA+0.5mM MoO4
2-
 WO4
2− 0.845±0.003 1600×108±6×108 6.30×10−3±0.02×10−3 −14.60 ± 0.04 
TupA+0.5mM WO4
2-
 MoO4
2− No displacement 
n = measured stoichiometry of binding 
 
 
Figure 4.8: Isothermal titration calorimetry of ligand binding to TupA. 10 µM of TupA was titrated with 
injections of 100 µM tungstate (A) and 100 µM molybdate (B); (C) Displacement titration of 10 µM TupA 
incubated with 0.5 nM molybdate, with injections of 100 µM tungstate. Data was fitted with ORIGIN 
software. The raw ITC data is shown in the top graphs.30 
 
The ITC assay in ModA aims to investigate if the reaction is exothermic and the 
interaction behavior between both ligands and ModA is similar to the previously described TupA 
(figure 4.9, table 4.2). However, the heat release of ModA is much lower than TupA and 
together with the tight binding nature of these isotherms we were unable to have an accurate fit 
to determine the KD value for both molybdate and tungstate. Displacement titrations were done 
with the protein saturated with 0.1 mM of each ligand and we could conclude that ModA binds 
both molybdate and tungstate with high affinities and also that it is unable to replace tungstate 
for molybdate or vice versa. In this case it was not possible to use the binding competition 
assay to calculate the KD as it was adopted for TupA.  
 
As molybdate and tungstate are very similar in their geometry and charge it can be 
proposed that transport systems might not be able to discriminate both anions. 92 
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Table 4.2 - ITC analysis data of oxoanion binding to ModA protein at 30 °C 
Protein (+oxoanion) Ligand n KA (M
−1
) KD (nM) ∆H (kcalmol
−1
) 
ModA 
 
WO4
2− 
 
0.820±0.01 
 
9×107 ± 8×107 
12±10 −1.900±0.007 
MoO4
2− 0.781±0.02 2×107 ± 1x107 43± 25 −2.70± 0.01 
ModA+0.1mM MoO4
2- WO4
2−  No displacement   
ModA+0.1mM WO4
2- MoO4
2−                             No displacement 
n = measured stoichiometry of binding 
 
 
 
 
 
 
 
 
 
Figure 4.9: Isothermal titration calorimetry of ligand binding to ModA. ModA (10 µM)was titrated with 
injections of 100 µM tungstate (A) and 100 µM molybdate (B). Data was fitted with ORIGIN software. The 
raw ITC data is shown in the top figures. 
 
In case of TupA_R118K the stoichiometry is around one mole oxoanion per mole of 
protein, as deduced from the heat release upon the addition of tungstate or molybdate to the 
protein solution (figure 4.10). Direct titration of tungstate against TupA_R118K produced an 
exothermic binding with a KD value of 1.8 ± 0.7 nM. The value of ΔHobs (~15.9 kcal/mole of 
injectant) is also more satisfactory when compared to the molybdate binding experiment. 
However, the extremely high affinity of the protein for tungstate resulted in a very steep binding 
curve which hampers the determination of the correct value of the KD. Analyzing the data from 
the molybdate binding we can see that the affinity between TupA_R118K and molybdate is 
lower than the tungstate and the equivalent binding for the wild type (figure 4.10 B; table 4.3). 
The data analysis shows clearly that TupA_R118K has a high affinity for tungstate and a lower 
affinity for molybdate. In addition, comparison of the data obtained for the recombinant wild type 
TupA protein and for TupA_R118K mutant shows that the mutant is more selective for 
tungstate.  
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To determine a reliable KD value for tungstate a binding competition strategy is required as 
mention in 4.5.4.1.However we still need to redo the titrations with molybdate to have a more reliable 
KD required for the displacement titration with tungstate. 
  
Table 4.3 –ITC analysis data of oxoanion binding to TupA_R118K protein at 30 °C 
Protein  Ligand N KA (M
−1
) KD (nM) ∆H (kcalmol
−1
) 
 
TupA_R118K 
 
WO4
2− 
 
1.160±0.002 
 
6 × 108± 2 × 108 
 
1.7±0.6 
 
−15.9±0.1 
MoO4
2− 1.04±0.03 6 × 106± 3 × 106 167±75 -0.78± 0.04 
n = measured stoichiometry of binding 
 
 
Figure 4.10: Isothermal titration calorimetry of ligand binding to TupA_R118K (raw and processed data). 
TupA_R118K (10 µM) was titrated with injections of 100 µM tungstate (A) and 100 µM molybdate (B). Data 
was fitted with ORIGIN software. The raw ITC data is shown in the top figures. 
 
Direct titration of tungstate against TupA_R118E produced a lower exothermic binding 
with a meaningless KD and stoichiometry value demonstrating there is no protein-metal binding. 
The same is true for molybdate (figure 4.10 B).  
The data analysis shows clearly that TupA_R118E has drastic decrease in affinity for 
tungstate and probably a nonspecific affinity for molybdate. Possibly to obtain a linear response 
between TupA_R118E and MoO4
2− we might have to use different protein and ligand 
concentration.  
A B 
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Figure 4.11: Isothermal titration calorimetry of ligand binding to TupA_R118E. TupA_R118E (10 µM) was 
titrated with injections of 100 µM tungstate (A) and 100 µM molybdate (B). Data was fitted with ORIGIN 
software. The raw ITC data is shown in the top graphs. 
 
Despite the results obtained from native polyacrylamide gel, the ITC revealed that 
TupAR118Q can bind tungstate (figure 4.12, table 4.4). This discrepancy could be related to the 
lower sensitive of the native polyacrylamide gel compared to the ITC experiment and this 
binding is not strong enough to be evident in the gel. The binding between TupA_R118Q and 
the metal is however lower than the binding of wild type TupA or TupA_R118K suggesting that 
the charge of the residue is very important for the coordination.  
Again, the result of the interaction between the protein and molybdate shows that there 
is no binding between them and the KD of the reaction could not be determined. 
 
Table 4.4 - ITC analysis data of oxoanion binding to ModA protein at 30 °C 
Protein  Ligand N KA (M
−1
) KD (nM) ∆H (kcalmol
−1
) 
 
TupA_R118Q 
 
WO4
2− 
 
0.647±0.002 
 
139x105± 6×105 
 
72±3  
 
−2.22±0.09 
MoO4
2− No determined 
n = measured stoichiometry of binding 
 
 
  
A B 
- 52 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Isothermal titration calorimetry of ligand binding to TupA_R118Q. 10 µM of TupA_R118Q 
was titrated with injections of 100 µM tungstate (A) and 100 µM molybdate (B). Data was fitted with 
ORIGIN software. The raw ITC data is shown in the top graphs 
 
4.5. X-ray crystallography 
 
 The first approach to crystallize the proteins under study consisted in testing several 
precipitating solutions for different protein concentrations and ratio of protein + precipitating 
solution in the crystallization drops in 96-well plates by the vapor diffusion sitting drop method. 
In addition to the commercial screens, an 80 conditions in-house screen (based on the screen 
of Jancarik et al)87 was tested as well as EWI/EWII and Additive Screen 1 and 2. 
 
4.5.1. TupA 
 
 The crystallization of recombinant TupA as well as data processing and structure 
resolution were done by the PhD student Ana Rita Cardoso. Nevertheless, the work was 
repeated so that the acquired know how could be applied to other datasets collected in the time 
course of this thesis.  
 
4.5.1.1. Crystallization studies and diffraction experiment 
 
To crystallize TupA from DaG20 several commercial screens were tested in 96-well 
plates using the sitting drop by vapor diffusion method. Plate shaped crystals appeared about 
four days after crystallization setup when using a solution of 0.2 M magnesium chloride, 0.1 M 
HEPES  pH 7.5 and 30% (w/v) polyethylene glycol 3350 as the precipitating agent, as 
mentioned in section 3.5.1 (figure 4.13).30 The scale-up optimization was done by changing the 
protein: precipitant ratio in the crystallization drop.  
  
A B 
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The same crystallization conditions were repeated with the main goal of producing more 
crystals for protein-ligand structure determination. Co-crystallization and soaking techniques 
were performed with tungstate and molybdate but with no success since in the presence of 
ligands the crystals no longer diffract the X-rays.  
 
 
 
 
 
 
 
Figure 4.13: TupA crystal grown in 0.2 M magnesium chloride, 0.1 M HEPES, pH 7.5 and 30% (w/v) 
polyethylene glycol 3350. 
Before harvesting the crystals a stabilizing solution known as harvesting buffer was 
added to the drops. As stated in section 3.5, this solution has the same composition of the 
crystallization solution except for a higher concentration of precipitant agent (32% of PEG 
3350), to avoid the crystals dissolution during handling. Before freezing in liquid nitrogen, the 
crystals were transferred to a cryoprotectant solution containing glycerol. This prevents the 
formation of ice which appears in the diffraction pattern in the form of rings, hence ensuring 
good data collection at cryogenic temperatures. 
The diffraction experiment was performed at the ESRF, at beamline ID 23-1 and the 
crystals obtained diffracted up to 1.43 Å resolution (figure 4.14, table 4.5). 
 
Figure 4.14: Diffraction pattern of the TupA crystal obtained at 20ºC. The experiment was carried out at 
beamline ID23-1 (ESRF - France) and the data collected have a maximum resolution of 1.43 Å (edge of 
the diffraction pattern)  
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The images (reflections) were indexed using MOSFLM program93 in order to determine 
the Miller indices hkl, the intensity (Ihkl) and their associated errors (σhkl). It is also possible to 
characterize the unit cell by determining the constants a, b, c and the α, β, γ angles. Thus, TupA 
crystal belongs to a monoclinic crystal system, with the cell constants: a = 52.25 Å; b = 42.50 Å; 
c = 54.71 Å; β = 95.43º.  
Through the analysis of the reflection intensities based on AIMLESS (part of the CCP4 
program) (Collaborative Computational Project Number 4) the most likely space group can be 
determined. In this case we concluded that the TupA crystal belongs to P1211 space group.  
During the diffraction experiment the crystal may be damaged (radiation damage), 
which can affect the reflection intensities. Thus it is necessary to scale the data because it is not 
possible to compare intensities that are not on the same scale. For TupA, data collection 
statistics are presented in table 4.5.  
 
 
 
 
 
 
 
Table 4.5: Data collection and processing statistics for the TupA crystal. Values in parentheses 
correspond to the highest resolution shell. 
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Data collection parameters 
X-ray source ID23-1 (ESRF, Grenoble) 
Detector PILATUS 6M-F 
Wavelength (Å) 0.954 
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Processing statistics 
Unit-cell parameters (Å, °) a = 52.25; b = 42.50; c = 54.71; β = 95.43 
Space group P1211 
Molecules per AU 1 
Matthews coefficient (Å3, Da) 2.09 
Mosaicity (°) 0.22 
Resolution range (Å) 42.50–1.43 (1.45–1.43) 
<I/σI> 10.3 (2.1) 
Rmerge (%) * 4.1 (33.5) 
Rpim (%) 
+
 2.7 (23.4) 
Rmeas (%) 
§ 5.0 (4.1) 
Multiplicity 3.0 (2.8) 
No. of observed reflections 132,115 (6,040) 
No. of unique reflections 43,950 (2,151) 
Completeness (%) 99.1 (98.8) 
 
The statistics presented in table 4.5 were thoroughly analyzed in order to attest the 
quality of the collected data. Each parameter is going to be described in detail in the following 
paragraphs. 
The mosaicity corresponds to the angular measure of the disorder degree of the unit 
cells in the crystal. Lower values of mosaicity (bellow 1) indicate better ordered crystals and as 
a result better diffraction patterns.94 Thus the mosaicity average of the crystal measured was 
0.22º indicating a good packing of the unit cells within the crystal.  
Another parameter to consider is the average of the ratio between the intensities and 
the associated error, <I/σI>. In this case the intensities are ten times higher than the error 
associated (<I/σI>. = 10.3) reflecting the high signal to noise ratio.69 
The resolution of 1.45-1.43 Å allows the determination of the protein structure, obtaining 
a model at an atomic level. Three other factors that also reveal the good quality of the data are 
the values of Rmerge, Rpim and Rmeas.  
The Rmerge is a measure of the agreement among multiple measurements of the same 
reflections in different frames or different datasets. 
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Useful data for structure determination should present values for the overall Rmerge 
ranging from 5% to 10% and, in this case, the overall Rmerge value obtained was 4.1%. The 
Rmerge for the highest resolution shell was 33.5% which is an acceptable value.
95 The Rpim value 
is equivalent to the previous but decreases with the increase of redundancy (multiplicity) and it 
will reflect the increasing accuracy (precision) of the intensities as more and more observations 
are merged57 This expresses the precision of the intensity average with a value of 2.7% for the 
experimental data. The Rmeas is introduced as the equivalent robust indicator for data 
consistency. It should accurately reflect the reliability of individual measurements, independently 
from multiplicity.96 
A diffraction experiment involves measuring a large number of reflection intensities. As 
crystals have intrinsic symmetry, some reflections are expected to be equivalent and 
consequently have equal intensity. The average number of measurements per individual 
symmetrically unique reflection is called redundancy or multiplicity. Because every reflection is 
measured with a certain degree of error, the higher the redundancy the more accurate the final 
estimation of the averaged reflection intensity will be.69 For this dataset, the multiplicity is 3.0. 
The completeness measures all the reflections that are collected and it should be as 
near as possible to 100%.57 In this case the global completeness was 99.1% and 98.8% for the 
highest resolution shell, showing that the data is appropriate for structure determination.  
As a final remark, the prior analysis revealed that the collected dataset was of good 
quality and could be used for structure determination, model construction and refinement. 
Prior to structure determination it is important to know the number of molecules in the 
asymmetric unit. The Matthews’s coefficient can provide this information since it is related to the 
solvent content.97 Both are calculated from the unit cell and the molecular weight of the 
molecules present. The Matthews coefficient calculation (2.09 Å3·Da−1) suggests the presence 
of one molecule of TupA per asymmetric unit and a solvent content of 40.84% 
 
 
4.5.1.2. Structure determination 
 
The available structures deposited in the Protein Data Bank (www.rscb.org) from the 
families of transporters ModA and TupA have a low sequence identity (16.5%)98, however they 
have a high degree of three-dimensional homology with very few structural differences. 
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In order to solve the TupA structure sequence alignments were performed, allowing to 
find the best homology models that could be used for molecular replacement (MR). Structure 
determination was performed with PHASER99 using as molecular models: a protein with 
unknown function from Vibrio parahaemolyticus  (PBD code 3MUQ) and the Gs TupA (PDB 
code 3LR1). 30 In the first trials to solve the phase problem the two homology models were 
superposed (figure 4.15). Nonetheless, a MR solution could only be acquired when searching 
for small sections of the protein individually. This procedure is generally used for large proteins, 
where a high degree of flexibility is expected, suggesting that DaG20 TupA is also a flexible 
protein that can assume multiple conformations.30 
Figure 4.15: PDB of 3LR1 (orange) and 3MUQ (pink) superposed in PyMOL program 
The TupA structure (figure 4.16 and figure 4.17) was determined using the data from 
table 4.5 and the structures presented in figure 4.15 after the structural superposition. It is 
possible to see the similarities of the envelope and also of some of elements of secondary 
structure between the two models (PDB: 3LR1 and PDB: 3MUQ) used to solve the structure of 
the protein TupA. The structure of Gs TupA was solved in presence of tungsten. The 
coordination of the metal is not well described and in fact it is in the form of W6+ and not the 
corresponding oxoanion, as expected. Nevertheless, it is clear that the folding of this structure 
with the ligand adopts a more compact conformation that the other free protein. This result 
corroborates the idea that TupA can have a close and open form and is in good agreement with 
the biochemical characterization performed by urea polyacrylamide gel electrophoresis for 
DaG20 TupA.  
Figures 4.16 and 4.17 show the superposition of the solved structure of TupA protein 
(purple) with the two models used for molecular replacement to solve the TupA structure (data 
not published). 
The structure is in the last steps of refinement and a manuscript is under preparation.100 
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Figure 4.16: Three dimensional structure of DaG20 TupA (purple) (data not published) superposed with 
the PDB 3LR1 (orange); the sphere in red represents the tungsten metal (W6+). The residues with lateral 
chains represent the conserved amino acids involved in the possible coordination 
Figure 4.17: Three dimensional structure of DaG20 TupA (purple) (data not published) superposed with 
the PDB: 3MUQ (pink). The residues with lateral chains represent the conserved amino acids involved in 
the possible coordination   
- 59 - 
 
4.5.2. TupA_R118K, TupA_R118E and TupA_R118Q 
 
4.5.2.2. Crystallization studies and diffraction experiments 
 
With the purpose of crystallizing the three TupA mutants, numerous commercial 
screens were tested in 96-well plates using the sitting drop vapor diffusion method. Crystals of 
the three protein mutants appeared about two days after crystallization setup when using a 
solution of 0.1 M magnesium chloride, 0.1 M MES (pH 6.5) and 30% (w/v) polyethylene glycol 
8000 as the precipitating agent as mentioned in section 3.5.3 (figure 4.18).  
The scale-up optimization was then performed using the exact same conditions with 
only some adjustments in the ratio of the protein+precipitant volume in the drop (1µL+1 µL or 2 
µL +1 µL).  
 
 
 
 
 
Figure 4.18: Crystals of the three mutated proteins. A: TupA_R118K (14 mg/mL); B: TupA_R118E (10 
mg/mL) and C: TupA_R118Q (11mg/mL). The three mutated forms in 0.1 M magnesium chloride, 0.1 M 
MES (pH 6.5) and 30% (w/v) polyethylene glycol 8000 with ~ 0.05x0.02x0.03 mm. 
 The harvesting buffer containing 32% of PEG 8000 was added to the drops prior to 
crystal harvesting, following the approach described for the crystal of TupA. 
The diffraction experiment occurred in Diamond Light Source at beamline ID I03, 
however no diffraction of the crystals was observed (figure 4.19A, 4.19B and 4.19C). Therefore 
new crystallization assays will be carried out with the main goal of obtaining good diffracting 
crystals and  complete datasets for each of the mutants. 
 
 
 
 
 
 
Figure 4.19: Diffraction pattern of the A: TupA_R118K, B: TupA_R118E and C: TupA_R118Q crystals 
obtained at 20ºC. The experiments were carried out at beamline ID03 (DLS – England)  
        A       B    C 
  A    B    C 
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4.5.3. ModA 
 
4.5.3.1. Crystallization Studies and diffraction experiment 
 
For ModA some commercial screens were also used to test in 96-well plates using the 
sitting drop by vapor diffusion method. Some needles appeared about five days after 
crystallization setup when using a solution of 28% (w/v) polyethylene glycol 6000, 0.1M sodium 
cacodylate (pH 6.5) and 0.2 M ammonium sulfate. To the scale-up optimization we changed the 
protein: precipitant ratio in the crystallization drops. New crystals were obtained again with a 
needle shape (figure 4.20 A). A diffraction experiment of the needles revealed poor resolution of 
the diffraction data (3.5 Å) (figure 4.21) and the crystallization condition was optimized using the 
additive screen 1 and 2 (Hampton Research). The crystals present in figure 4.20 B were 
obtained using the additive benzamidine hydrochloride at a final concentration of 20% (w/v) 
from the Additive Screen 1. These are plate shape crystals, larger than the previous and easier 
to manipulate with, probably, a better diffraction (figure 4.22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20: ModA crystals. A: Crystals growth in 28% (w/v) polyethylene glycol 6000, 0.1 M sodium 
cacodylate (pH 6.5) and 0.2 M ammonium sulfate. B:  Crystals growth in 28% (w/v) polyethylene glycol 
6000, 0.1 M sodium cacodylate (pH 6.5) and 0.2 M ammonium sulfate and 20% (w/v) of benzamidine 
hydrochloride. 
To harvest the crystals, the harvesting buffer, containing 30% of PEG 6000, was added 
to the drops following the methodology described above for the TupA crystal. 
The crystals shown in figure 4.19A were used to collect a complete dataset in the ESRF 
at beamline ID 23-1, diffracting up to 3.5 Å (figure 4.21, table 4.6). The plate crystals presented 
in figure 4.20B were also used to collect a dataset in the DLS at ID I03, where one of the 
crystals diffracted up to 2 Å resolution (figure 4.22. table 4.7). 
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Figure 4.21: Diffraction pattern of the ModA crystal obtained at 20ºC. The experiment was carried out at 
the beamline ID23-1 (ESRF - France) and the data collected has a maximum resolution of 3.5 Å. 
 
 
 
 
 
 
 
 
 
 
Figure 4.22: Diffraction pattern of the ModA crystal obtained at 20ºC. The experiment was carried out at 
beamline ID03 (DLS - England) and the data collected has a maximum resolution of 2.77 Å. 
 
The data were indexed using MOSFLM.93. The crystals belong to two different space 
groups: C21, with cell constants a = 178.31; b = 103.22; c = 61.53; β = 90.05º for the crystals 
with maximum resolution of 3.5 Å and P21, with cell constants a = 56.98; b = 103.9; c = 91.89; β 
= 105.3º, for the better diffracting crystals. In spite of the differences in cell units and space 
groups, the crystalline system is the same for the two crystal forms, monoclinic. This difference 
can result from the packing of the crystals.  
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After these steps, we used the XDS package and AIMLESS from CCP4 package to 
scale and evaluate the data quality, resulting in the statistical parameters present in tables 4.6 
and 4.7. The obtained values show the quality of the collected data for both crystal forms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.6: Data collection and processing statistics for the ModA crystal (figure 4.19A). Values in 
parentheses correspond to the highest resolution shell 
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Data collection parameters 
Parameters ModA (without additive) ModA (with additive) 
X-ray source ID 23-1 (ESRF, France) ID I03 (Diamond, England) 
PILATUS3 6M 
0.969 
Detector PILATUS 6M-F  
Wavelength (Å) 0.954 
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 Data analysis shows that the two collected datasets are of good quality and  as a final 
remark, the prior analysis revealed that the second dataset collected was of good and with 
better quality that the first one, and could be used for model construction and refinement. 
 
4.5.3.2. Structural insights on ModA from DaG20 
 
The structure of ModA from Da G20 with the 2.77 Å resolution has not solved yet. 
However, it is possible to speculate about the likely structure, based on the similar proteins of 
ModA from other organisms. 
The ModA protein from E.coli K12 was one of the proteins used to perform the 
alignment with the other species of Desulfovibrio (figure 4.1.) with the main goal of determining 
the amino acids most likely involved in the coordination of ligands. This protein from E.coli K12 
has already been solved and the structure is available at the PDB.  
Processing statistics 
Parameters ModA (without additive) ModA (with additive) 
Unit-cell parameters (Å, °) 
a = 178.31; b = 103.22; c = 61.53; β = 
90.05 
a = 56.98; b = 103.9; c = 91.89; β 
= 90.05 
Space group C1211 P1211 
Molecules per AU 4 4 
Matthews coefficient (Å3, Da) 2.62 2.43 
Mosaicity (°) 0.20 0.20 
Resolution range (Å) 44.67–3.50 (3.69–3.50) 48.59–2.77 (2.92–2.77) 
<I/σI>  7.0(3.5)  8.3(2.2) 
Rmerge (%) * 11.7(34.5) 17.8(72.8) 
Rpim (%) 
+
 9.2 (28.2) 10.6 (51.1) 
Rmeas (%) 
§ 15.0 (4.48) 20.7 (98.6) 
Multiplicity 2.2 (2.2) 3.7 (3.6) 
No. of observed reflections 27081 (3938) 96383(13573) 
No. of unique reflections 12080 (1767) 26279(3804) 
Completeness (%) 85.2 (86.8) 99.6 (99.6) 
- 64 - 
 
In order to understand the structural/conformational behavior of ModA protein from Da 
G20 in presence and absence of its ligands, it was performed a Homology detection & structure 
prediction by HHpred tool and three structures of ModA with some identity were found. 
The ModA binding WO4 from Azotobacter vinelandii (PDB: 1ATG), ModA binding ReO4
- 
from E.coli K12 (PDB: 3R26) and ModA from Clostridium difficile (PDB: 4KD5). The 
superposition of the three structures is present in figure 4.23.  
Figure 4.23: Three dimensional structures of ModA superposed (E.coli K12 numbering): ModA from 
Azotobacter vinelandii with WO4 interactions (PDB: 1ATG) in blue, ModA from Clostridium difficile (PDB: 
4KD5) in green and ModA binding ReO4
- from E.coli K12 (PDB 3R26) in grey. The residues with different 
shades represent the conserved amino acids involved in the possible coordination.  
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The ModA from E.coli K12 shares 25% identity and 0.418 similarity with ModA from Da 
G20, the ModA from Azotobacter vinelandii, 35% of identity and 0.594 similarity and ModA from 
Clostridium difficile shares 26% of identity and 0.417 of similarity. The crystal structures of 
ModA from Av and also from Ec K12 have been solved complexed with metals. On the other 
hand, the uncomplexed ModA from Clostridium difficile exhibits an open conformation meaning 
that the secondary and tertiary structures between the ModA from Av and ModA from Ec K12 
are very similar. Once again, this result is in good agreement with the biochemical 
characterization of ModA protein. 
In order to understand the binding and metal transport of ModA and TupA a 
superposition of TupA from Da G20 and the ModA from Clostridium difficile was performed 
(figure 4.24). 
 
Figure 4.24: Three dimensional structures of TupA (purple) from Da G20 (not published) superposed with 
ModA PDB 4KD5 (green)  
 
In the superposition one can see that the two proteins share the same envelope 
although differences are found in the second and tertiary structure elements of the proteins. The 
position of the amino acids involved in the coordination of the metals is also different which 
could be explained by the binding specificity. However our biochemical data shows that the 
proteins are capable of binding the two metals and more experiments are required to better 
understand this question. 
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4.5.4. Small angle X-ray scattering 
 
This technique can be applied to biological molecules of different molecular weights and 
different natures. In the case of proteins, this technique is a very important tool for 
conformational analysis and structural changes evaluation, in solution. SAXS provides a model 
of the protein envelope which can be used to complement the high resolution data obtained by 
X-ray crystallography, including the more flexible regions of the protein.101 
SAXS was applied to study Da ModA in the absence and in the presence of molybdate 
and tungstate ligands. The datasets were processed through the ATSAS software88 which 
subtracts each buffer contribution to each protein concentration. This software is able to define 
the Guinier analysis which determines the radius of gyration (Rg) and the zero scattering angle 
intensity, I (0). In case of monodisperse samples, the plot is supposed to be linear, whereby the 
line slope gives us the Rg and its intersection with the ordinate provides the scattering intensity. 
The I (0) value normalized to the solute concentration is proportional to the molecular mass of 
the solute.102 For this determination it is important to perform an assay with a standard protein, 
BSA, in order to determinate proportionality constant. 
Once the Rg is determined as well as the I (0), the next step is to use the GNOM 
program to determine the maximum linear dimension, Dmax
 and the interatomic distance 
distribution functions p(r). The last one is calculated from an indirect Fourier transform of the 
scattering between all of the electrons within the macromolecular structure. 103 
To the shape determination we used the DAMMIN program. This algorithm represents 
the shape by densely packed beads in a controlled search volume. The final results (figure 4.25, 
figure 4.26 and figure 4.27) are PDB files that have been superposed in PyMOL with the PDB 
file of the protein with the highest identity resulted from the ModA alignment in HHpred tool. This 
corresponds to ModA of Azotobacter vinelandii (PDB code 1ATG). The superposition shows 
that the two proteins are quite similar, with the same folding. Nevertheless some differences are 
found, namely a few loops at the surface of the protein. These can be derived from the not so 
high sequence homology (35%) or by the fact that, in solution, the proteins have more degrees 
of freedom. 
The Guiner analysis as well the GNOM can be seen in the figures 4.25, 4.26, 4.27 and 
also in the table 4.8 for ModA, ModA+Mo and ModA+W, respectively. These tables include the 
radius of gyration, the maximum particle dimension and the excluded volume of the hydrated 
particle.  The molecular mass (MM) of the solute estimated from the scattering intensity are 
close to the ModA sequence (26761.9 Da). 
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Figure 4.25.: Superposition of PDB 1ATG and the model resulted from SAXS experiment of ModA. The 
WO4 ligand is in red 
 
 
Figure 4.26.: Superposition of PDB 1ATG and the model resulted from SAXS experiment of ModA with 
molybdate. The WO4 ligand is in red 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.27.: Superposition of PDB 1ATG and the model resulted from SAXS experiment of ModA with 
tungstate. The WO4 ligand is in red 
 
  
180º 
180º 
180º 
- 68 - 
 
Table 4.7 – Data analysis of ModA by SAXS experiment 
SAXS analysis 
ModA 
Guinier GNOM 
Rg (nm) 2.040 ± 0.017 Quality estimate 63.20% 
I0 28.400±0.102 Reciprocal Space Rg/I0 2.11    26.54 
Fidelity 0.989 Real Space Rg/I0 2.11    26.54 
MM 28.52 KDa 
Porod Volume 40.31 
Dmax 6.73 
ModA+Mo 
Rg (nm) 1.910 ± 0.008 Quality estimate 72.60% 
I0 27.700±0.077 Reciprocal Space Rg/I0 1.93    26.05 
Fidelity 0.925 Real Space Rg/I0 1.93    26.05 
MM 27.8 KDa 
Porod Volume 41.23 
Dmax 6.01 
ModA+W 
Rg 1.820 ± 0.016 Quality estimate 73.40% 
I0 27.500±0.089 Reciprocal Space Rg/I0 1.91    28.42 
Fidelity 0.987 Real Space Rg/I0 1.91    28.42 
MM 27.6 KDa 
Porod Volume 37.56 
Dmax 5.77 
 
Analyzing the apo and holoproteins scattering profiles (figure 4.28), some differences 
are found mainly when ModA is bound to tungstate suggesting that probably in solution ModA 
adopts a more close conformation when interacting with tungstate. All this small differences 
between the apo and the holoproteins will be reflected in the final shape/envelope of the protein 
calculated by DAMMIN as we can see in figures 4.25, 4.26 and 4.27. 
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Figure 4.28.: Scattering profile of ModA (red), ModA+Mo (green) and ModA+W (blue) by SAXS. 
 
 
 
These results are in agreement with the biochemical data here described where open 
and closed forms were speculated. Other techniques as NMR or circular dichrohism (CD) can 
be useful to detect conformational alterations and the mass spectroscopy (MS) to confirm the 
presence of the metal. 
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5. Final Remarks 
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Molybdenum and tungsten enzymes are extensively distributed in biology and can be 
found in all domains of life.1, 3, 18, 29 These are crucial elements, which play key roles in 
numerous metabolic pathways, catalyzing essential reactions of the biochemical cycles of the 
more abundant elements on the earth. Usually, both Mo and W are part of enzymes that 
catalyze redox processes involving the transfer of an atom from the substrate to the metal ion or 
vice versa.18 They catalyze some of the main reactions in the metabolism of carbon, nitrogen 
and sulfur by microorganisms, plants and animals, besides a small number of species that do 
not require molybdenum uses tungsten for the same purpose. 
 
In order to be physiologically relevant and enable enzymes to perform its function, both 
Mo and W must be bound to organic cofactors, Moco or Wco, respectively. Despite Mo and W 
share several chemical characteristics, unspecific incorporation of the metal atom in the 
catalytic site of the proteins sometimes yields less active and even inactive enzymes14, 18, 19. The 
Mo and W cellular uptake is performed through specific transport systems (ModABC and 
TupABC) in which the component A (ModA/TupA) is proposed as the first selection gate to 
these elements. Which structural characteristics make the component A able to discriminate 
between these homologous elements still as an open question. 
 
To give insights about the features that could contribute to the specificity of these 
proteins, in the present master thesis were studied both TupA and ModA from a functional and 
structural point of view. 
 
Initially, it was mutated the positively charged R118 of TupA that was proposed as one 
of the responsible for the oxoanion coordination and to afford the high selectivity of the TupA 
proteins. Arginine 118 was replaced by three amino acids with different charges: lysine 
(positively charged, pI=10.76), glutamine (neutral, pI=3.22) and glutamic acid (negatively 
charged, pI=5.65). The expression conditions were optimized and a purification protocol was 
established for the three mutants. When this process was accomplished, it was performed a 
biochemical characterization which includes the experimental determination of the extinction 
coefficient, binding studies with metal oxoanions and determination of stoichiometry, association 
constant and enthalpy (n, KD and ΔH) by ITC.  
 
The value of the experimental extinction coefficients of mutants were in good agreement 
with the theoretically calculated values. 
 
The native polyacrylamide gels showed that TupA and ModA can bind ligands, 
molybdate and tungstate, the mutation of R118 to R118K avoids the molybdate binding but not 
the tungstate coordination. The gels also showed that the mutation of R118 to neutral or 
negatively charged residue blocks ligand binding, which means that the arginine is an important 
amino acid involved in the coordination of metals.  
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The analysis of the urea-polyacrylamide gel suggests that there is a conformational 
change of the proteins upon ligand binding. In case of TupA and the TupA_R118K, the proteins 
probably adopt a more compact conformation when bound to tungstate but not for molybdate. 
 
However, for ModA, the urea-polyacrylamide gel showed that this protein bind both 
ligands with very high and similar affinity, adopting also, a compact conformation. 
 
After the competition assays, the ITC data showed an extremely low KD value 
(6.30×10−3 nM) for TupA from DaG20 saturated with molybdate and titrated with tungstate. This 
is in agreement with the homologous protein WtpA from P.furiosus. Using the ITC technique 
was observed that WtpA bind both anions, tungstate (KD=17×10
−3 nM) and molybdate (KD=11 
nM). The apparent KD for tungstate when the protein is saturated with molybdate was 
determined to be 15 nM 28. A displacement titration of the tungstate-saturated TupA with 
molybdate was also done and no displacement occurred. This suggests that TupA binds very 
tightly both ligands, however, with higher affinity to tungstate than to molybdate. The same 
strategy could not be adopted for ModA since this protein binds with high affinity/specificity both 
ligands, meaning that the KD determined has a high error associated. However the 
stoichiometry determined (n=1) is in good agreement to that expected for both proteins. Related 
to the mutated forms of TupA, only the TupA_R118K showed affinity for tungstate (KD = 1.7 nM) 
with a very low binding for molybdate and a stoichiometry of approximately 1. The TupA_R118Q 
exhibits the lowest binding with tungstate (KD = 72 nM), however with the stoichiometry below 
expected (n=0.647). Only the TupA_R118E does not exhibit any binding for molybdate or 
tungstate, which is in agreement with the native gel electrophoresis studies.  
 
Previous to this master thesis work, the TupA was crystallized, and the tridimensional 
structure was solved and under refinement. After this, co-crystallization and soaking techniques 
were performed in order to understand the conformational behavior of the protein in presence of 
ligands, molybdate and tungstate. However, the several conditions tested so far not allowed 
crystallizing any of the protein-ligand complexes under study. Regarding the mutated forms of 
TupA, these were successfully crystallized, but their tridimensional structure could not be 
obtained because the crystals did not diffract properly. Crystallization screening of the mutant 
using new crystallization conditions and in the presence of ligands is under way. SAXS 
experiments are also planned to the near future where conformational changes of the protein in 
the presence and absence of the two different ligands can be addressed. 
 
Regarding to the crystal structure of ModA, a complete dataset had been previously 
collected at 3.5 Å resolution.  To improve the resolution optimization trials were carried out and 
a diffraction pattern with higher resolution (2.77 Å) was successfully obtained. The structure is 
currently being solved and superposition of some reported ModA structures show similarities in 
the envelopes and in some elements of secondary structure.104-106 In addition, crystallization of 
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ModA in presence of both ligands is also currently being performed. A low resolution structural 
model for this protein was obtained using SAXS experiments. The scattering data obtained 
provides the envelope of the protein, which in fact is very similar to the periplasmic protein 
ModA from Azotobacter vinelandii, also responsible for the transport of molybdate.105 
 
Finally, in order to understand the differences/similarities between both proteins (TupA 
and ModA) from the two transporter systems, the structure solved of TupA from DaG20 was 
superposed with the ModA from Clostridium difficile.106 Here, the envelope of the two proteins 
are also analogous, however the secondary and tertiary structures show some differences, as 
expected.  
 
The preliminary functional and structural characterization of the component A of both 
ABC transport systems present in this work contributes to the deeper understanding of these 
kind of systems. Particularly regarding to the TupA protein, it was not only proved the relevance 
of the arginine 118 of TupA on the oxoanion coordination but also was obtained a mutant 
(TupA_R118K) with higher specificity towards tungstate. 
 
Besides the crystallization experiments that are under way, other techniques for 
structural and biochemical characterization could be used to better understand this class of 
transporters (namely circular dichroism or Nuclear Magnetic Resonance). For now, 
establishment of a metal specific variant of TupA is already quite an achievement that opens the 
way for future biological applications. 
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Appendix I  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 7.1: Representation of crystalline systems 
 
Appendix II 
 
Table 7.1: LB media composition for 1 L for the growth of E.coli which is prepared with distilled water and 
it is submitted to the autoclave at 120º for 20 minutes  
LB media 
NaCl (Scharlau) 5 g 
Tryptone (Bacto™) 10 g 
Yeast Extract (Cultimed) 5 g 
 
Table 7.2: Autoinduction media composition for 100 mL for the growth of E.coli which is prepared with 
distilled water and it is submitted to the autoclave at 120º for 20 minutes  
Autoinduction media 
MgSO4 (Sigma-Aldrich) 100 µL of 1M 
50x52 Solution* 2 mL 
20xNPS Solution** 5 mL 
LB media 93 mL 
  
*50x52 Solution STOCK  (no autoclave) 
Glycerol (Scharlau) 25% (v/v) 
Glucose (Sigma-Aldrich) 2.5% (v/v) 
α-Lactose (Sigma-Aldrich) 10% (v/v) 
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**20xNPS Solution STOCK 
(NH4)2SO4 (Panreac) 25 mM 
KH2PO4 (Sigma-Aldrich) 
50  mM 
Na2HPO4 (Sigma-Aldrich) 
 
 
 
Appendix III 
 
 
Table 7.3.: Composition of the solutions employed 
 
Stock Solutions Concentration Gel (mL) Running Gel (mL) 
Solution I - 0.166 
Solution II 0.9 - 
Solution III 0.45 1.49 
H2O 2.15 3.34 
PSA 10% (w/v) (μL) 27 25 
TEMED (μL) 4 2.5 
  
Table 7.4.:  Composition of the solutions employed 
Solution Composition 
I Tris-HCl 1 M pH 8.8 
II Tris-HCl 0.5 M pH 6.8 
III Acrylamide/Bis Solution, 40:30% 
  
Table 7.5.: Composition of the sample buffer for 1X. 
  Concentration 
Tris-HCl pH 6.8 125 mM 
Glycerol 10% (v/v) 
Bromophenol 
Blue 
0.02% (w/v) 
 
 
Table 7.6.:Composition of the loading buffer for 1X. 
 
  Concentration 
Tris-HCl pH 8.3 25 mM 
Glycine 192 mM 
SDS * 0.1% 
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Appendix IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2.: pET-46 Ek/LIC vector map and sequence previously used to clone the tupA gene 
and consequently used for the mutagenesis procedure 
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Appendix V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.: Expression tests in E.coli with 100  mL of media of each mutant of TupA. A: TupA_R118K ; M: 
Marker, (1-4): Induction 30ºC, (1): BL21 soluble fraction, (2): BL21 insoluble fraction, (3): Ros soluble 
fraction, (4): Ros insoluble fraction; (5-8): Autoinduction 30ºC, (5): BL21 soluble fraction, (6): BL21 
insoluble fraction, (7): Ros soluble fraction, (8): Ros insoluble fraction; B: TupA_R118E; M: Marker, (1-4): 
Induction 30ºC, (1): BL21 soluble fraction, (2): BL21 insoluble fraction, (3): Ros soluble fraction, (4): Ros 
insoluble fraction; (5-8): Autoinduction 30ºC, (5): BL21 soluble fraction, (6): BL21 insoluble fraction, (7): 
Ros soluble fraction, (8): Ros insoluble fraction; C: TupA_R118Q M: Marker, (1-4): Induction 30ºC, (1): 
BL21 soluble fraction, (2): BL21 insoluble fraction, (3): Ros soluble fraction, (4): Ros insoluble fraction; (5-
8): Autoinduction 30ºC, (5): BL21 soluble fraction, (6): BL21 insoluble fraction, (7): Ros soluble fraction, 
(8): Ros insoluble fraction; D: Induction 19ºC, M: Marker, (1-4): TupA_R118E, 1): BL21 soluble fraction, 
(2): BL21 insoluble fraction, (3): Ros soluble fraction, (4): Ros insoluble fraction, (5-8): TupA_R118Q, (5): 
BL21 soluble fraction, (6): BL21 insoluble fraction, (7): Ros soluble fraction, (8): Ros insoluble fraction. 
  
1        2       M      3      4        5      6         7       8              1       2        3     M      4     5       6        7       8 
A       B 
1        2      3      4      M      5       6     7       8                    1       M      2     3      4       5       6        7       8 
C       D 
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Figure 7.4.: Expression tests in E.coli with 100 mL of media of each mutant of TupA. A: TupA_R118K, 
Induction 19ºC and Tuner cells ; M: Marker, (1-2): 100 µM of IPTG, (1): soluble fraction, (2): insoluble 
fraction, (3-4): 300 µM of IPTG, (3): soluble fraction, (4): insoluble fraction; (5-6): 500 µM of IPTG (5): 
soluble fraction, (6): insoluble fraction, (7-8): 800 µM of IPTG, (7): soluble fraction, (8): insoluble fraction; 
B: TupA_R118K, Induction 30ºC and Tuner cells; M: Marker, (1-2): 100 µM of IPTG, (1): soluble fraction, 
(2): insoluble fraction, (3-4): 300 µM of IPTG, (3): soluble fraction, (4): insoluble fraction; (5-6): 500 µM of 
IPTG (5): soluble fraction, (6): insoluble fraction, (7-8): 800 µM of IPTG, (7): soluble fraction, (8): insoluble 
fraction, C: TupA_R118E, Induction 19ºC and Tuner cells, M: Marker, (1-2): 100 µM of IPTG, (1): soluble 
fraction, (2): insoluble fraction, (3-4): 300 µM of IPTG, (3): soluble fraction, (4): insoluble fraction; (5-6): 500 
µM of IPTG (5): soluble fraction, (6): insoluble fraction, (7-8): 800 µM of IPTG, (7): soluble fraction, (8): 
insoluble fraction; D: TupA_R118E, Induction 30ºC, M: Marker, (1-2): 100 µM of IPTG, (1): soluble fraction, 
(2): insoluble fraction, (3-4): 300 µM of IPTG, (3): soluble fraction, (4): insoluble fraction; (5-6): 500 µM of 
IPTG (5): soluble fraction, (6): insoluble fraction, (7-8): 800 µM of IPTG, (7): soluble fraction, (8): insoluble 
fraction. 
  
 M       1       2      3      4       5       6       7       8                  1       M      2     3      4       5       6     7       8 
A       B 
C       D 
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Figure 7.5.: Expression tests in E.coli with 100  mL of media of each mutant of TupA. A: TupA_R118Q, 
Induction 19ºC and Tuner cells ; M: Marker, (1-2): 100 µM of IPTG, (1): soluble fraction, (2): insoluble 
fraction, (3-4): 300 µM of IPTG, (3): soluble fraction, (4): insoluble fraction; (5-6): 500 µM of IPTG (5): 
soluble fraction, (6): insoluble fraction, (7-8): 800 µM of IPTG, (7): soluble fraction, (8): insoluble fraction; 
B: TupA_R118Q, Induction 30ºC and Tuner cells; M: Marker, (1-2): 100 µM of IPTG, (1): soluble fraction, 
(2): insoluble fraction, (3-4): 300 µM of IPTG, (3): soluble fraction, (4): insoluble fraction; (5-6): 500 µM of 
IPTG (5): soluble fraction, (6): insoluble fraction, (7-8): 800 µM of IPTG, (7): soluble fraction, (8): insoluble 
fraction, C: TupA_R118E and TupA_R118Q,  Origami cells, M: Marker, (1-2): TupA_R118E, Induction 
19ºC, (1): soluble fraction, (2): insoluble fraction, (3-4): TupA_R118E, Induction 30ºC, (3): soluble fraction, 
(4): insoluble fraction; (5-6): TupA_R118Q, Induction 19ºC, (5): soluble fraction, (6): insoluble fraction, (7-
8): TupA_R118Q, Induction 30ºC, (7): soluble fraction, (8): insoluble fraction. 
  
A       B 
   1        2       .3       4       M      5       6       7       8                1       2       3      4     5       M      6       7       8 
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Figure 7.6.: Purification protocol used for mutated forms of TupA, according with TupA purification. (1-3): 
TupA_R118K, (1): Crude, (2): Ionic exchange chromatography (DEAE), (3): Gel filtration chromatography 
(Superdex 75), (4-6): TupA_R118E, (4): Crude, (5): Ionic exchange chromatography (DEAE), (6): Gel 
filtration chromatography (Superdex 75), (7-9): TupA_R118Q, (7): Crude, (8): Ionic exchange 
chromatography (DEAE) and (9): Gel filtration chromatography (Superdex 75) 
 
 
 
Appendix VII 
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Figure 7.7.: Extinction coefficient for TupA_R118K determined from the slope of the curve obtained by 
linear regression of the absorbance at 280 nm vs protein concentration 
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Figure 7.8.: Extinction coefficient for TupA_R118E determined from the slope of the curve obtained by 
linear regression of the absorbance at 280 nm vs protein concentration 
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Figure 7.9.: Extinction coefficient for TupA_R118EQ determined from the slope of the curve obtained by 
linear regression of the absorbance at 280 nm vs protein concentration. 
  
- 97 - 
 
Appendix VIII – Screening based on Jancarik et al 
 
1. 0.1 M Acetate pH=4.5; 0.2 M CaCl2; 30% MPD  
2. 0.1 M MES pH=6.5; 1 M K2/Na2C4H4O6;  
3. 0.4 M (NH4)2PO4  
4. 0.1 M Tris-HCl pH=8.5; 3 M (NH4)2SO4 
5. 0.1 M HEPES pH=7.5; 0.2 M Na3C6H5O7; 30% MPD  
6. 0.1 M Acetate pH=4.5; 0.2 M MgCl2; 30% PEG 4K  
7. 0.1 M HEPES pH=7.5; 1.2 M Na3C6H5O7 
8. 0.2 M Na3C6H5O7 
9. 0.1 M Citrate pH=5.5; 0,2 M CH3COONH4; 30% PEG 400  
10. 0.1 M Acetate pH=4.5; 1.5 M NH4HPO4 
11. 0.1 M HEPES pH=7.5; 1.5 M K2HPO4; 1.5 M NaH2PO4; 0.2 M (NH4)2SO4 
12. 0.1 M Tris-HCl pH=8.5; 0.2 M Na3C6H5O7; 20% PEG 400  
13. 0.1 M HEPES pH=7.5; 0.2 M CaCl2; 25% PEG 4K  
14. 0.1 M MES pH=6.5; 0.1 M MgCl2; 30% PEG 8K  
15. 0.1 M Citrate pH=5.5; 0.2M Li2SO4; 30% PEG 4K  
16. 0.1 M Acetate pH=4.5; 1 M Li2SO4 
17. 0.1 M Tris-HCl pH=7.5; 0.2 M NH4HPO4; 30% MPD  
18. 0.1 M Tris-HCl pH=7.5; 0.2 M CH3COONH4; 1.5 M K2HPO4; 1.5 M NaH2PO4 
19. 0.1 M Citrate pH=5.5; 0.1 M (NH4)2SO4; 30% PEG 8K  
20. 0.1 M MES pH=6.5; 30% MPD  
21. 0.1 M HEPES pH=7.5; 0.2 M MgCl2; 30% PEG 4K  
22. 0.1 M Tris-HCl pH=8.5; 0.2 M NaCH3COO; 30% PEG 4K  
23. 0.1 M Tris-HCl pH=7.5; 1 M K2/Na2C4H4O6;  
24. 0.1 M Tris-HCl pH=8.5; 0.2 M CaCl2 
25. 0.1 M Citrate pH=5.5; 0.5 M NH4CH3COO; 30% MPD  
26. 0.1 M MES pH=6.5; 2 M CH3COONa 
27. 0.1 M MES pH=6.5; 0.2 M K2/Na2C4H4O6; 30% PEG 8K  
28. 0.1 M HEPES pH=7.5; 1 M K2/Na2C4H4O6 
29. 0.1 M Acetato pH=4.5; 0.2 M (NH4)2SO4; 30% PEG 400  
30. 0.1 M HEPES pH=7.5; 0,1 M (NH4)2SO4; 20% PEG 4K  
31. 0.1 M MES pH=6.5; 2 M (NH4)2SO4 
32. 0.1 M MES pH=6.5; 0.2 M NaCl; 30% CH3CH2OH 
33. 0.1 M HEPES pH=7.5; 0.2 M MgCl2; 30% CH3CH2OH  
34. 0.1 M Tris-HCl pH=8.5; 0.2 M NH4CH3COO; 30% CH3CH2OH  
35. 0.1 M Acetate pH=4,5; 0.2 M CaCl2; 30% CH3CH2OH  
36. 0.1 M HEPES pH=7.5; 0.2 M NaCH3COO; 30% CH3CH2OH  
37. 0.1 M HEPES pH=7.5; 0.2 M MgCl2; 30% C3H8O  
38. 0.1 M Cacodylate pH=6.5; 30% MPD  
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39. 0.1 M Acetate pH=4.5; 2 M NaHCOO  
40. 0.1 M Cacodylate pH=6.5; 0.2 M Na3C6H5O7; 40% C3H8O  
41. 0.1 M HEPES pH=7.5; 20% PEG 400; 10% C3H8O  
42. 0.1 M HEPES pH=7.5; 1 M Li2SO4  
43. 0.1 M Tris-HCl pH=8.5; 0.2 M Li2SO4; 30% PEG 4K  
44. 0.1 M Cacodylate pH=6.5; 0.2 M (NH4)2SO4; 30% PEG 6K  
45. 0.1 M Acetate pH=4.5; 1.5 M NaCH3COO 
46. 0.1 M Na3C6H5O7; 1 M NH4 H2PO4 
47. 4 M NaHCOO  
48. 0.1 M HEPES pH=7.5; 1.2 M Na3C6H5O7; 
49. 0.4 M K2/Na2C4H4O6 
50. 0.1 M Tris-HCl pH=8.5; 0.2 M MgCl2; 30% PEG 4K  
51. 0.1 M Cacodylate pH=6.5; 1.4 M NaCH3COO 
52. 0.1 M Citrate pH=5.5; 0.2 M NH4CH3COO; 30% PEG 4K  
53. 0.1 M Citrate pH=4.5; 0.2 M NH4CH3COO, 30% PEG 4K  
54. 0.1 M HEPES pH=7.5; 0.2 M CaCl2; 28% PEG 400  
55. 0.1 M Cacodylate pH=6.5; 0.2 M (NH4)2SO4; 30% PEG 8K  
56. 0.1 M Cacodylate pH=6.5; 0.2 M Mg(CH3COO)2; 30% PEG 8K  
57. 0.1 M Tris-HCl pH=8.5; 0.2 M NH4CH3COO; 30% C3H8O  
58. 0.1 M Acetate pH=4.5; 0.2 M (NH4)2SO4; 25% PEG 4K  
59. 0.1 M Cacodylate pH=6.5; 0.2 M Mg(CH3COO)2; 30% MPD  
60. 0.1 M Acetate pH=4.5; 0.2 M CaCl2; 20 % C3H8O  
61. 0.1 M Imidazol pH=7; 1 M NaCH3COO;  
62. 0.1 M Cacodylate pH=6.5; 0,2 M Na3C6H5O7; 20 % C3H8O  
63. 0.1 M Cacodylate pH=6.5; 0.2 M NaCH3COO; 30% PEG 8K  
64. 0.2 M (NH4)2SO4; 30% PEG 8K  
65. 0.2 M (NH4)2SO4; 30% PEG 4K  
66. 0.1 M HEPES pH=7.5; 1.6 M K2HPO4; 1.6 M NaH2PO4 
67. 0.1 M Tris-HCl pH=8.5; 8% PEG 8K  
68. 0.1 M Acetate pH=4.5; 8% PEG 4K  
69. 0.1 M HEPES pH=7.5; 1.8 M NH4 H2 PO4; 2% PEG 400  
70. 0.1 M Citrate pH=5.5; 20% PEG 4K; 20 % C3H8O  
71. 0.05 M K2HPO4; 20% PEG 8K  
72. 30% PEG 1K  
73. 0.2 M Mg(HCOO)2  
74. 0.1 M Cacodylate pH=6.5; 0.2 M Zn(CH3COO)2; 18% PEG 8K  
75. 0.1 M Cacodylate pH=6.5; 0.2 M Ca(CH3COO)2; 18% PEG 8K  
76. 0.1 M Acetate pH=4.5; 2 M (NH4)2SO4 
77. 0.1 M Tris-HCl pH=8.5; 2 M (NH4)2SO4 
78. 1 M Li2SO4; 2% PEG 8K  
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79. 0.5 M Li2SO4; 18% PEG 8K  
80. 0.1 M Citrate pH=5.5; 0.2 M NH4CH3COO; 20 % PEG 4K; 20 % C3H8O 
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